{
"instance": {
"moh-20200630.htm": {
"axisCustom": 1,
"axisStandard": 21,
"contextCount": 231,
"dts": {
"calculationLink": {
"local": [
"moh-20200630_cal.xml"
]
},
"definitionLink": {
"local": [
"moh-20200630_def.xml"
],
"remote": [
"http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
"http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
]
},
"inline": {
"local": [
"moh-20200630.htm"
]
},
"labelLink": {
"local": [
"moh-20200630_lab.xml"
],
"remote": [
"http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
"https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
]
},
"presentationLink": {
"local": [
"moh-20200630_pre.xml"
]
},
"referenceLink": {
"remote": [
"http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
"https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
]
},
"schema": {
"local": [
"moh-20200630.xsd"
],
"remote": [
"http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
"http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd",
"http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
"http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
"http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
"http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
"https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
"http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
"https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
"https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
"http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
"http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
"http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
]
}
},
"elementCount": 456,
"entityCount": 1,
"hidden": {
"http://fasb.org/us-gaap/2020-01-31": 4,
"http://www.molinahealthcare.com/20200630": 3,
"http://xbrl.sec.gov/dei/2019-01-31": 5,
"total": 12
},
"keyCustom": 50,
"keyStandard": 293,
"memberCustom": 25,
"memberStandard": 32,
"nsprefix": "moh",
"nsuri": "http://www.molinahealthcare.com/20200630",
"report": {
"R1": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "document",
"isDefault": "true",
"longName": "0001001 - Document - Cover Page",
"role": "http://www.molinahealthcare.com/role/CoverPage",
"shortName": "Cover Page",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R10": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:EarningsPerShareTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2111103 - Disclosure - Net Income per Share",
"role": "http://www.molinahealthcare.com/role/NetIncomeperShare",
"shortName": "Net Income per Share",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:EarningsPerShareTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R11": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FairValueDisclosuresTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2114104 - Disclosure - Fair Value Measurements",
"role": "http://www.molinahealthcare.com/role/FairValueMeasurements",
"shortName": "Fair Value Measurements",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FairValueDisclosuresTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R12": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2119105 - Disclosure - Investments",
"role": "http://www.molinahealthcare.com/role/Investments",
"shortName": "Investments",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R13": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "moh:MedicalClaimsAndBenefitsPayableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2125106 - Disclosure - Medical Claims and Benefits Payable",
"role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable",
"shortName": "Medical Claims and Benefits Payable",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "moh:MedicalClaimsAndBenefitsPayableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R14": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:LongTermDebtTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2130107 - Disclosure - Debt",
"role": "http://www.molinahealthcare.com/role/Debt",
"shortName": "Debt",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:LongTermDebtTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R15": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2134108 - Disclosure - Stockholders' Equity",
"role": "http://www.molinahealthcare.com/role/StockholdersEquity",
"shortName": "Stockholders' Equity",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R16": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SegmentReportingDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2139109 - Disclosure - Segments",
"role": "http://www.molinahealthcare.com/role/Segments",
"shortName": "Segments",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SegmentReportingDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R17": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2143110 - Disclosure - Commitments and Contingencies",
"role": "http://www.molinahealthcare.com/role/CommitmentsandContingencies",
"shortName": "Commitments and Contingencies",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R18": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "moh:ConsolidationAndInterimFinancialInformationPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2204201 - Disclosure - Significant Accounting Policies (Policies)",
"role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies",
"shortName": "Significant Accounting Policies (Policies)",
"subGroupType": "policies",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "moh:ConsolidationAndInterimFinancialInformationPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R19": {
"firstAnchor": {
"ancestors": [
"us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
"ix:continuation",
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2305301 - Disclosure - Significant Accounting Policies (Tables)",
"role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables",
"shortName": "Significant Accounting Policies (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
"ix:continuation",
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R2": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:PremiumsEarnedNet",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1001002 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
"role": "http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
"shortName": "CONSOLIDATED STATEMENTS OF INCOME",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:PremiumsEarnedNet",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R20": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2312302 - Disclosure - Net Income per Share (Tables)",
"role": "http://www.molinahealthcare.com/role/NetIncomeperShareTables",
"shortName": "Net Income per Share (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R21": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2315303 - Disclosure - Fair Value Measurements (Tables)",
"role": "http://www.molinahealthcare.com/role/FairValueMeasurementsTables",
"shortName": "Fair Value Measurements (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R22": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2320304 - Disclosure - Investments (Tables)",
"role": "http://www.molinahealthcare.com/role/InvestmentsTables",
"shortName": "Investments (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R23": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2326305 - Disclosure - Medical Claims and Benefits Payable (Tables)",
"role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables",
"shortName": "Medical Claims and Benefits Payable (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R24": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2331306 - Disclosure - Debt (Tables)",
"role": "http://www.molinahealthcare.com/role/DebtTables",
"shortName": "Debt (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R25": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2335307 - Disclosure - Stockholders' Equity (Tables)",
"role": "http://www.molinahealthcare.com/role/StockholdersEquityTables",
"shortName": "Stockholders' Equity (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R26": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2340308 - Disclosure - Segments (Tables)",
"role": "http://www.molinahealthcare.com/role/SegmentsTables",
"shortName": "Segments (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R27": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": "INF",
"first": true,
"lang": "en-US",
"name": "us-gaap:NumberOfReportableSegments",
"reportCount": 1,
"unitRef": "segment",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2402401 - Disclosure - Organization and Basis of Presentation (Details)",
"role": "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"shortName": "Organization and Basis of Presentation (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i37097661e9c14dfb89282d1440260b77_I20200630",
"decimals": "INF",
"lang": "en-US",
"name": "us-gaap:NumberOfStatesInWhichEntityOperates",
"reportCount": 1,
"unique": true,
"unitRef": "state",
"xsiNil": "false"
}
},
"R28": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"ix:continuation",
"ix:continuation",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2406402 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents (Details)",
"role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashandCashEquivalentsDetails",
"shortName": "Significant Accounting Policies - Cash and Cash Equivalents (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"ix:continuation",
"ix:continuation",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i48c240f05e094c3ea73de75a535eb82d_I20190630",
"decimals": "-6",
"lang": "en-US",
"name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R29": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "moh:InvestmentsMaturityPeriod",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2407403 - Disclosure - Significant Accounting Policies - Narrative (Details)",
"role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails",
"shortName": "Significant Accounting Policies - Narrative (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "moh:InvestmentsMaturityPeriod",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R3": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
"role": "http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
"shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-6",
"lang": "en-US",
"name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R30": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ReservesReportedToOtherAgenciesTextBlock",
"us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "moh:MedicalPremiumsLiabilityMedicalCareCostsThreshold",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2408404 - Disclosure - Significant Accounting Policies - Amounts Due To Government Agencies (Details)",
"role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails",
"shortName": "Significant Accounting Policies - Amounts Due To Government Agencies (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ReservesReportedToOtherAgenciesTextBlock",
"us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "moh:MedicalPremiumsLiabilityMedicalCareCostsThreshold",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R31": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"moh:QualityIncentivePremiumRevenueRecognizedTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "moh:MaximumAvailableQualityIncentivePremiumCurrentYear",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2409405 - Disclosure - Significant Accounting Policies - Quality Incentive Premium Revenue Recognized (Details)",
"role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails",
"shortName": "Significant Accounting Policies - Quality Incentive Premium Revenue Recognized (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"moh:QualityIncentivePremiumRevenueRecognizedTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "moh:MaximumAvailableQualityIncentivePremiumCurrentYear",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R32": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:ReceivablesNetCurrent",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2410406 - Disclosure - Significant Accounting Policies - Receivables (Details)",
"role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails",
"shortName": "Significant Accounting Policies - Receivables (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ic94ae01ecf3049fcae620fd4f2952730_I20200630",
"decimals": "-6",
"lang": "en-US",
"name": "us-gaap:ReceivablesNetCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R33": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2413407 - Disclosure - Net Income per Share (Details)",
"role": "http://www.molinahealthcare.com/role/NetIncomeperShareDetails",
"shortName": "Net Income per Share (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-5",
"lang": "en-US",
"name": "us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R34": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"ix:continuation",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2416408 - Disclosure - Fair Value Measurements - Fair Value of Financial Instruments on Recurring Basis (Details)",
"role": "http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails",
"shortName": "Fair Value Measurements - Fair Value of Financial Instruments on Recurring Basis (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"lang": "en-US",
"name": "us-gaap:AssetsFairValueDisclosure",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R35": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:FairValueByBalanceSheetGroupingTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i75a81965990c4e75a35b337fdac100a4_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2417409 - Disclosure - Fair Value Measurements - Balance Sheet Grouping (Details)",
"role": "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails",
"shortName": "Fair Value Measurements - Balance Sheet Grouping (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:FairValueByBalanceSheetGroupingTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i75a81965990c4e75a35b337fdac100a4_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R36": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:ProceedsFromConvertibleDebt",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2418410 - Disclosure - Fair Value Measurements - Details of Long-Term Debt (Details)",
"role": "http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails",
"shortName": "Fair Value Measurements - Details of Long-Term Debt (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ieca34debeaad47fcab6644cd719f18c9_D20200101-20200331",
"decimals": "-6",
"lang": "en-US",
"name": "us-gaap:ProceedsFromConvertibleDebt",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R37": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2421411 - Disclosure - Investments - Summary of Investments (Details)",
"role": "http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails",
"shortName": "Investments - Summary of Investments (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"ix:continuation",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"lang": "en-US",
"name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R38": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2422412 - Disclosure - Investments - Contractual Maturities of Available-for-Sale Investments (Details)",
"role": "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails",
"shortName": "Investments - Contractual Maturities of Available-for-Sale Investments (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R39": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGain",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2423413 - Disclosure - Investments - Narrative (Details)",
"role": "http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails",
"shortName": "Investments - Narrative (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGain",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R4": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"ix:continuation",
"ix:continuation",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1003004 - Statement - CONSOLIDATED BALANCE SHEETS",
"role": "http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS",
"shortName": "CONSOLIDATED BALANCE SHEETS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"lang": "en-US",
"name": "us-gaap:MarketableSecuritiesCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R40": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2424414 - Disclosure - Investments - Available-for-Sale Investments (Details)",
"role": "http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails",
"shortName": "Investments - Available-for-Sale Investments (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R41": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2427415 - Disclosure - Medical Claims and Benefits Payable - Medical Claims and Benefits Payable (Details)",
"role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandBenefitsPayableDetails",
"shortName": "Medical Claims and Benefits Payable - Medical Claims and Benefits Payable (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R42": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "moh:MedicalClaimsAndBenefitsPayable",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2428416 - Disclosure - Medical Claims and Benefits Payable - Narrative (Details)",
"role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableNarrativeDetails",
"shortName": "Medical Claims and Benefits Payable - Narrative (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "moh:MedicalClaimsAndBenefitsPayable",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R43": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"ix:continuation",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i01845f518fd84f498539398ec799e869_I20191231",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2429417 - Disclosure - Medical Claims and Benefits Payable - Components of Change in Medical Claims and Benefits Payable (Details)",
"role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails",
"shortName": "Medical Claims and Benefits Payable - Components of Change in Medical Claims and Benefits Payable (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"ix:continuation",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": "-6",
"lang": "en-US",
"name": "us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R44": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"ix:continuation",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2432418 - Disclosure - Debt - Schedule of Long-Term Debt (Details)",
"role": "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"shortName": "Debt - Schedule of Long-Term Debt (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"ix:continuation",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R45": {
"firstAnchor": {
"ancestors": [
"us-gaap:GainsLossesOnExtinguishmentOfDebt",
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-3",
"first": true,
"lang": "en-US",
"name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2433419 - Disclosure - Debt - Narrative (Details)",
"role": "http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"shortName": "Debt - Narrative (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"us-gaap:GainsLossesOnExtinguishmentOfDebt",
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-3",
"first": true,
"lang": "en-US",
"name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R46": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i6b87f22cc66640bca8f41a1336d1db57_D20200101-20200331",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:StockRepurchasedDuringPeriodValue",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2436420 - Disclosure - Stockholders' Equity - Narrative (Details)",
"role": "http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails",
"shortName": "Stockholders' Equity - Narrative (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-6",
"lang": "en-US",
"name": "us-gaap:ShareBasedCompensation",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R47": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i01845f518fd84f498539398ec799e869_I20191231",
"decimals": "INF",
"first": true,
"lang": "en-US",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2437421 - Disclosure - Stockholders' Equity - Share Activity (Details)",
"role": "http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails",
"shortName": "Stockholders' Equity - Share Activity (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i01845f518fd84f498539398ec799e869_I20191231",
"decimals": "INF",
"first": true,
"lang": "en-US",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R48": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"ix:continuation",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2438422 - Disclosure - Stockholders' Equity - Fair Value of Awards Granted and Vested (Details)",
"role": "http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails",
"shortName": "Stockholders' Equity - Fair Value of Awards Granted and Vested (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"ix:continuation",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R49": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": "INF",
"first": true,
"lang": "en-US",
"name": "us-gaap:NumberOfReportableSegments",
"reportCount": 1,
"unitRef": "segment",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2441423 - Disclosure - Segments - Narrative (Details)",
"role": "http://www.molinahealthcare.com/role/SegmentsNarrativeDetails",
"shortName": "Segments - Narrative (Details)",
"subGroupType": "details",
"uniqueAnchor": null
},
"R5": {
"firstAnchor": {
"ancestors": [
"us-gaap:CommonStockParOrStatedValuePerShare",
"span",
"div",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "INF",
"first": true,
"lang": "en-US",
"name": "us-gaap:CommonStockParOrStatedValuePerShare",
"reportCount": 1,
"unique": true,
"unitRef": "usdPerShare",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
"role": "http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
"shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
"subGroupType": "parenthetical",
"uniqueAnchor": {
"ancestors": [
"us-gaap:CommonStockParOrStatedValuePerShare",
"span",
"div",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i7b15bc7a360b49ea876cfd9ef8a1f199_I20200630",
"decimals": "INF",
"first": true,
"lang": "en-US",
"name": "us-gaap:CommonStockParOrStatedValuePerShare",
"reportCount": 1,
"unique": true,
"unitRef": "usdPerShare",
"xsiNil": "false"
}
},
"R50": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ie0e955507d44442da1f7262dc9018a43_D20200401-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:Revenues",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2442424 - Disclosure - Segments - Reconciliation of Gross Margin to Consolidated Income (Details)",
"role": "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails",
"shortName": "Segments - Reconciliation of Gross Margin to Consolidated Income (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "ia045098da1b242d1baa89d8e1d358d4d_D20200401-20200630",
"decimals": "-6",
"lang": "en-US",
"name": "us-gaap:Revenues",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R6": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"ix:continuation",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i86f3d9af809b4b7d8d3c396d852faeb6_I20181231",
"decimals": "-5",
"first": true,
"lang": "en-US",
"name": "us-gaap:SharesOutstanding",
"reportCount": 1,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
"role": "http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
"shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i922d546f43ee453ba9ed85e9354e4d52_D20190101-20190331",
"decimals": "-6",
"lang": "en-US",
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R7": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": "-6",
"first": true,
"lang": "en-US",
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
"role": "http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": "-6",
"lang": "en-US",
"name": "us-gaap:DepreciationDepletionAndAmortization",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R8": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2101101 - Disclosure - Organization and Basis of Presentation",
"role": "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation",
"shortName": "Organization and Basis of Presentation",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R9": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SignificantAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2103102 - Disclosure - Significant Accounting Policies",
"role": "http://www.molinahealthcare.com/role/SignificantAccountingPolicies",
"shortName": "Significant Accounting Policies",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"body",
"html"
],
"baseRef": "moh-20200630.htm",
"contextRef": "i0253d5cb303c4b09822c99848b51e635_D20200101-20200630",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SignificantAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
}
},
"segmentCount": 59,
"tag": {
"dei_AmendmentFlag": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
"label": "Amendment Flag",
"terseLabel": "Amendment Flag"
}
}
},
"localname": "AmendmentFlag",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_CityAreaCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Area code of city",
"label": "City Area Code",
"terseLabel": "City Area Code"
}
}
},
"localname": "CityAreaCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_CoverAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cover page.",
"label": "Cover [Abstract]",
"terseLabel": "Cover [Abstract]"
}
}
},
"localname": "CoverAbstract",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"xbrltype": "stringItemType"
},
"dei_CurrentFiscalYearEndDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "End date of current fiscal year in the format --MM-DD.",
"label": "Current Fiscal Year End Date",
"terseLabel": "Current Fiscal Year End Date"
}
}
},
"localname": "CurrentFiscalYearEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "gMonthDayItemType"
},
"dei_DocumentFiscalPeriodFocus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
"label": "Document Fiscal Period Focus",
"terseLabel": "Document Fiscal Period Focus"
}
}
},
"localname": "DocumentFiscalPeriodFocus",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "fiscalPeriodItemType"
},
"dei_DocumentFiscalYearFocus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
"label": "Document Fiscal Year Focus",
"terseLabel": "Document Fiscal Year Focus"
}
}
},
"localname": "DocumentFiscalYearFocus",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "gYearItemType"
},
"dei_DocumentPeriodEndDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
"label": "Document Period End Date",
"terseLabel": "Document Period End Date"
}
}
},
"localname": "DocumentPeriodEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "dateItemType"
},
"dei_DocumentQuarterlyReport": {
"auth_ref": [
"r475"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true only for a form used as an quarterly report.",
"label": "Document Quarterly Report",
"terseLabel": "Document Quarterly Report"
}
}
},
"localname": "DocumentQuarterlyReport",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentTransitionReport": {
"auth_ref": [
"r476"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true only for a form used as a transition report.",
"label": "Document Transition Report",
"terseLabel": "Document Transition Report"
}
}
},
"localname": "DocumentTransitionReport",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentType": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
"label": "Document Type",
"terseLabel": "Document Type"
}
}
},
"localname": "DocumentType",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "submissionTypeItemType"
},
"dei_EntityAddressAddressLine1": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Address Line 1 such as Attn, Building Name, Street Name",
"label": "Entity Address, Address Line One",
"terseLabel": "Entity Address, Address Line One"
}
}
},
"localname": "EntityAddressAddressLine1",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressCityOrTown": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the City or Town",
"label": "Entity Address, City or Town",
"terseLabel": "Entity Address, City or Town"
}
}
},
"localname": "EntityAddressCityOrTown",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressPostalZipCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Code for the postal or zip code",
"label": "Entity Address, Postal Zip Code",
"terseLabel": "Entity Address, Postal Zip Code"
}
}
},
"localname": "EntityAddressPostalZipCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressStateOrProvince": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the state or province.",
"label": "Entity Address, State or Province",
"terseLabel": "Entity Address, State or Province"
}
}
},
"localname": "EntityAddressStateOrProvince",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "stateOrProvinceItemType"
},
"dei_EntityCentralIndexKey": {
"auth_ref": [
"r477"
],
"lang": {
"en-US": {
"role": {
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
"label": "Entity Central Index Key",
"terseLabel": "Entity Central Index Key"
}
}
},
"localname": "EntityCentralIndexKey",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "centralIndexKeyItemType"
},
"dei_EntityCommonStockSharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
"label": "Entity Common Stock, Shares Outstanding",
"terseLabel": "Entity Common Stock, Shares Outstanding"
}
}
},
"localname": "EntityCommonStockSharesOutstanding",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "sharesItemType"
},
"dei_EntityCurrentReportingStatus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Current Reporting Status",
"terseLabel": "Entity Current Reporting Status"
}
}
},
"localname": "EntityCurrentReportingStatus",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityEmergingGrowthCompany": {
"auth_ref": [
"r477"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate if registrant meets the emerging growth company criteria.",
"label": "Entity Emerging Growth Company",
"terseLabel": "Entity Emerging Growth Company"
}
}
},
"localname": "EntityEmergingGrowthCompany",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_EntityFileNumber": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
"label": "Entity File Number",
"terseLabel": "Entity File Number"
}
}
},
"localname": "EntityFileNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "fileNumberItemType"
},
"dei_EntityFilerCategory": {
"auth_ref": [
"r477"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Filer Category",
"terseLabel": "Entity Filer Category"
}
}
},
"localname": "EntityFilerCategory",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "filerCategoryItemType"
},
"dei_EntityIncorporationStateCountryCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Two-character EDGAR code representing the state or country of incorporation.",
"label": "Entity Incorporation, State or Country Code",
"terseLabel": "Entity Incorporation, State or Country Code"
}
}
},
"localname": "EntityIncorporationStateCountryCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "edgarStateCountryItemType"
},
"dei_EntityInteractiveDataCurrent": {
"auth_ref": [
"r478"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
"label": "Entity Interactive Data Current",
"terseLabel": "Entity Interactive Data Current"
}
}
},
"localname": "EntityInteractiveDataCurrent",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityRegistrantName": {
"auth_ref": [
"r477"
],
"lang": {
"en-US": {
"role": {
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
"label": "Entity Registrant Name",
"terseLabel": "Entity Registrant Name"
}
}
},
"localname": "EntityRegistrantName",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityShellCompany": {
"auth_ref": [
"r477"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
"label": "Entity Shell Company",
"terseLabel": "Entity Shell Company"
}
}
},
"localname": "EntityShellCompany",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_EntitySmallBusiness": {
"auth_ref": [
"r477"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
"label": "Entity Small Business",
"terseLabel": "Entity Small Business"
}
}
},
"localname": "EntitySmallBusiness",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_EntityTaxIdentificationNumber": {
"auth_ref": [
"r477"
],
"lang": {
"en-US": {
"role": {
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
"label": "Entity Tax Identification Number",
"terseLabel": "Entity Tax Identification Number"
}
}
},
"localname": "EntityTaxIdentificationNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "employerIdItemType"
},
"dei_LocalPhoneNumber": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Local phone number for entity.",
"label": "Local Phone Number",
"terseLabel": "Local Phone Number"
}
}
},
"localname": "LocalPhoneNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_Security12bTitle": {
"auth_ref": [
"r473"
],
"lang": {
"en-US": {
"role": {
"documentation": "Title of a 12(b) registered security.",
"label": "Title of 12(b) Security",
"terseLabel": "Title of 12(b) Security"
}
}
},
"localname": "Security12bTitle",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "securityTitleItemType"
},
"dei_SecurityExchangeName": {
"auth_ref": [
"r474"
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the Exchange on which a security is registered.",
"label": "Security Exchange Name",
"terseLabel": "Security Exchange Name"
}
}
},
"localname": "SecurityExchangeName",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "edgarExchangeCodeItemType"
},
"dei_TradingSymbol": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Trading symbol of an instrument as listed on an exchange.",
"label": "Trading Symbol",
"terseLabel": "Trading Symbol"
}
}
},
"localname": "TradingSymbol",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CoverPage"
],
"xbrltype": "tradingSymbolItemType"
},
"moh_A4.875SeniorNotesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "4.875% Senior Notes [Member]",
"label": "4.875% Senior Notes [Member]",
"terseLabel": "4.875% Notes due 2025",
"verboseLabel": "4.875% Notes"
}
}
},
"localname": "A4.875SeniorNotesMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"moh_A4375SeniorNotesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "4.375% Senior Notes",
"label": "4.375% Senior Notes [Member]",
"terseLabel": "4.375% Notes"
}
}
},
"localname": "A4375SeniorNotesMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Net Payable",
"label": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Net Payable",
"terseLabel": "Risk adjustment, net payable"
}
}
},
"localname": "AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayableReceivablePriorYears": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Net (Payable) Receivable, Prior Years",
"label": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Net (Payable) Receivable, Prior Years",
"terseLabel": "Risk adjustment, net payable, prior year"
}
}
},
"localname": "AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayableReceivablePriorYears",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, (Payable)",
"label": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, (Payable)",
"negatedLabel": "Risk adjustment payable"
}
}
},
"localname": "AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Receivable",
"label": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Receivable",
"terseLabel": "Risk adjustment receivable"
}
}
},
"localname": "AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayableCurrentYear": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Receivable (Payable), Current Year",
"label": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Receivable (Payable), Current Year",
"negatedTerseLabel": "Risk adjustment, net payable, current year"
}
}
},
"localname": "AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayableCurrentYear",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails": {
"order": 1.0,
"parentTag": "moh_QualityIncentivePremiumRevenueRecognized",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of current year quality incentive premium revenue recognized.",
"label": "Amount Of Current Year Quality Incentive Premium Revenue Recognized",
"terseLabel": "Earned current period"
}
}
},
"localname": "AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails": {
"order": 2.0,
"parentTag": "moh_QualityIncentivePremiumRevenueRecognized",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of quality incentive premium revenue recognized from prior year.",
"label": "Amount Of Quality Incentive Premium Revenue Recognized From Prior Year",
"terseLabel": "Earned prior periods"
}
}
},
"localname": "AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
"order": 3.0,
"parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amounts Due To Government Agencies, Marketplace, Medical Loss Ratio Threshold",
"label": "Amounts Due To Government Agencies, Marketplace, Medical Loss Ratio Threshold",
"terseLabel": "Minimum MLR"
}
}
},
"localname": "AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Amounts Due To Government Agencies, Marketplace Program [Abstract]",
"label": "Amounts Due To Government Agencies, Marketplace Program [Abstract]",
"terseLabel": "Marketplace program:"
}
}
},
"localname": "AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
],
"xbrltype": "stringItemType"
},
"moh_AmountsDueToGovernmentAgenciesMedicaidOther": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
"order": 2.0,
"parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amounts Due To Government Agencies, Medicaid, Other",
"label": "Amounts Due To Government Agencies, Medicaid, Other",
"terseLabel": "Other"
}
}
},
"localname": "AmountsDueToGovernmentAgenciesMedicaidOther",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Amounts Due To Government Agencies, Medicaid Program [Abstract]",
"label": "Amounts Due To Government Agencies, Medicaid Program [Abstract]",
"terseLabel": "Medicaid program:"
}
}
},
"localname": "AmountsDueToGovernmentAgenciesMedicaidProgramAbstract",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
],
"xbrltype": "stringItemType"
},
"moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
"order": 6.0,
"parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amounts Due To Government Agencies, Medicare, Medical Loss Ratio And Profit Sharing, Threshold",
"label": "Amounts Due To Government Agencies, Medicare, Medical Loss Ratio And Profit Sharing, Threshold",
"terseLabel": "Minimum MLR and profit sharing"
}
}
},
"localname": "AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Amounts Due To Government Agencies Medicare Program",
"label": "Amounts Due To Government Agencies Medicare Program [Abstract]",
"terseLabel": "Medicare program:"
}
}
},
"localname": "AmountsDueToGovernmentAgenciesMedicareProgramAbstract",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
],
"xbrltype": "stringItemType"
},
"moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
"order": 8.0,
"parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amounts Due to Government Agencies, Risk Adjustment and Part D risk sharing",
"label": "Amounts Due to Government Agencies, Risk Adjustment and Part D risk sharing",
"terseLabel": "Risk adjustment and Part D risk sharing"
}
}
},
"localname": "AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AmountsDuetoGovernmentAgenciesOther": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
"order": 1.0,
"parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amounts Due to Government Agencies, Other",
"label": "Amounts Due to Government Agencies, Other",
"terseLabel": "Other"
}
}
},
"localname": "AmountsDuetoGovernmentAgenciesOther",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AmountsDuetoGovernmentAgenciesRiskAdjustment": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
"order": 7.0,
"parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amounts Due to Government Agencies, Risk Adjustment",
"label": "Amounts Due to Government Agencies, Risk Adjustment",
"terseLabel": "Risk adjustment"
}
}
},
"localname": "AmountsDuetoGovernmentAgenciesRiskAdjustment",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_AssetAcquisitionAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Asset Acquisition",
"label": "Asset Acquisition [Axis]",
"terseLabel": "Asset Acquisition [Axis]"
}
}
},
"localname": "AssetAcquisitionAxis",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "stringItemType"
},
"moh_AssetAcquisitionDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Asset Acquisition",
"label": "Asset Acquisition [Domain]",
"terseLabel": "Asset Acquisition [Domain]"
}
}
},
"localname": "AssetAcquisitionDomain",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "domainItemType"
},
"moh_COVID19Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "COVID-19",
"label": "COVID-19 [Member]",
"terseLabel": "COVID-19"
}
}
},
"localname": "COVID19Member",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"moh_CaliforniaIllinoisNewMexicoOhioSouthCarolinaTexasWashingtonandWisconsinMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "California, Illinois, New Mexico, Ohio, South Carolina, Texas, Washington, and Wisconsin [Member]",
"label": "California, Illinois, New Mexico, Ohio, South Carolina, Texas, Washington, and Wisconsin [Member]",
"terseLabel": "Select health plans"
}
}
},
"localname": "CaliforniaIllinoisNewMexicoOhioSouthCarolinaTexasWashingtonandWisconsinMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "domainItemType"
},
"moh_CallOptionDerivativeAssetMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Call Option, Derivative Asset [Member]",
"label": "Call Option, Derivative Asset [Member]",
"terseLabel": "Call option"
}
}
},
"localname": "CallOptionDerivativeAssetMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
],
"xbrltype": "domainItemType"
},
"moh_CapitationClaimsPayable": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandBenefitsPayableDetails": {
"order": 3.0,
"parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Capitation Claims Payable",
"label": "Capitation Claims Payable",
"terseLabel": "Capitation payable"
}
}
},
"localname": "CapitationClaimsPayable",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_CashConvertibleSeniorNotesDue2020Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cash Convertible Senior Notes due 2020 [Member]",
"label": "Cash Convertible Senior Notes due 2020 [Member]",
"netLabel": "1.125% Convertible notes",
"terseLabel": "1.125% Convertible Notes, net of unamortized discount"
}
}
},
"localname": "CashConvertibleSeniorNotesDue2020Member",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"moh_CashConvertibleSeniorNotesDue2020WarrantsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cash Convertible Senior Notes Due 2020, Warrants [Member]",
"label": "Cash Convertible Senior Notes Due 2020, Warrants [Member]",
"terseLabel": "1.125% Warrants"
}
}
},
"localname": "CashConvertibleSeniorNotesDue2020WarrantsMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"moh_CashPaidForSettlementOfConversionOption": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 7.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Cash Paid For Settlement Of Conversion Option",
"label": "Cash Paid For Settlement Of Conversion Option",
"negatedTerseLabel": "Cash paid for partial settlement of conversion option"
}
}
},
"localname": "CashPaidForSettlementOfConversionOption",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"moh_CertainAssetsOfPassportHealthPlanMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Certain Assets Of Passport Health Plan",
"label": "Certain Assets Of Passport Health Plan [Member]",
"terseLabel": "Certain assets of passport health plan"
}
}
},
"localname": "CertainAssetsOfPassportHealthPlanMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "domainItemType"
},
"moh_ClassOfWarrantOrRightStatedInterestRate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Class Of Warrant Or Right, Stated Interest Rate",
"label": "Class Of Warrant Or Right, Stated Interest Rate",
"terseLabel": "Stated percentage of warrants"
}
}
},
"localname": "ClassOfWarrantOrRightStatedInterestRate",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "percentItemType"
},
"moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Components Of Change In Medical Claims And Benefits Payable [Table Text Block]",
"label": "Components Of Change In Medical Claims And Benefits Payable [Table Text Block]",
"terseLabel": "Components of Components of Change in Medical Claims and Benefits Payable"
}
}
},
"localname": "ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables"
],
"xbrltype": "textBlockItemType"
},
"moh_ComponentsOfMedicalCareCostsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Components of medical care costs.",
"label": "Components Of Medical Care Costs [Abstract]",
"terseLabel": "Components of medical care costs related to:"
}
}
},
"localname": "ComponentsOfMedicalCareCostsAbstract",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "stringItemType"
},
"moh_ConsolidatedNetLeverage": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Consolidated Net Leverage",
"label": "Consolidated Net Leverage",
"terseLabel": "Consolidated net leverage ratio"
}
}
},
"localname": "ConsolidatedNetLeverage",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "pureItemType"
},
"moh_ConsolidationAndInterimFinancialInformationPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Consolidation And Interim Financial Information, Policy [Policy Text Block]",
"label": "Consolidation And Interim Financial Information, Policy [Policy Text Block]",
"terseLabel": "Consolidation and Interim Financial Information"
}
}
},
"localname": "ConsolidationAndInterimFinancialInformationPolicyPolicyTextBlock",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"moh_ContractTermAdditionalRenewals": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Contract Term, Additional Renewals",
"label": "Contract Term, Additional Renewals",
"terseLabel": "Additional contract term"
}
}
},
"localname": "ContractTermAdditionalRenewals",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "integerItemType"
},
"moh_ContractTermRenewalPeriod": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Contract Term, Renewal Period",
"label": "Contract Term, Renewal Period",
"terseLabel": "Contract term renewal option period"
}
}
},
"localname": "ContractTermRenewalPeriod",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "durationItemType"
},
"moh_CurrentAssetsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Current Assets [Member]",
"label": "Current Assets [Member]",
"verboseLabel": "Current assets: Prepaid expenses and other current assets"
}
}
},
"localname": "CurrentAssetsMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
],
"xbrltype": "domainItemType"
},
"moh_CurrentLiabilitiesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Current Liabilities [Member]",
"label": "Current Liabilities [Member]",
"verboseLabel": "Current liabilities: Accounts payable, accrued liabilities and other"
}
}
},
"localname": "CurrentLiabilitiesMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
],
"xbrltype": "domainItemType"
},
"moh_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position [Abstract]",
"label": "Debt Securities, Available-For-Sale, Unrealized Loss Position [Abstract]",
"terseLabel": "Estimated Fair Value"
}
}
},
"localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAbstract",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails"
],
"xbrltype": "stringItemType"
},
"moh_DetailsofchangeinfairvalueofderivativesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Details of change in fair value of derivatives",
"label": "Details of change in fair value of derivatives [Abstract]",
"terseLabel": "Details of change in fair value of derivatives, net:"
}
}
},
"localname": "DetailsofchangeinfairvalueofderivativesAbstract",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "stringItemType"
},
"moh_GovernmentReceivablesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Government Receivables [Member]",
"label": "Government Receivables [Member]",
"terseLabel": "Government receivables"
}
}
},
"localname": "GovernmentReceivablesMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
],
"xbrltype": "domainItemType"
},
"moh_HealthCareInsuranceFeeLiability": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Health Care Insurance, Fee, Liability",
"label": "Health Care Insurance, Fee, Liability",
"terseLabel": "HIF liabilities"
}
}
},
"localname": "HealthCareInsuranceFeeLiability",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_HealthCareOrganizationInsurerFeeExpense": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 4.0,
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Health Care Organization, Insurer Fee Expense",
"label": "Health Care Organization, Insurer Fee Expense",
"terseLabel": "Health insurer fees"
}
}
},
"localname": "HealthCareOrganizationInsurerFeeExpense",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"moh_HealthCareOrganizationInsurerFeeRevenue": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 3.0,
"parentTag": "us-gaap_Revenues",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Health Care Organization, Insurer Fee Revenue",
"label": "Health Care Organization, Insurer Fee Revenue",
"terseLabel": "Health insurer fees reimbursed"
}
}
},
"localname": "HealthCareOrganizationInsurerFeeRevenue",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"moh_HealthCareOrganizationPremiumTaxRevenue": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 2.0,
"parentTag": "us-gaap_Revenues",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Health Care Organization, Premium Tax Revenue",
"label": "Health Care Organization, Premium Tax Revenue",
"terseLabel": "Premium tax revenue"
}
}
},
"localname": "HealthCareOrganizationPremiumTaxRevenue",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"moh_HealthInsurerFeeReimbursementReceivablesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Health Insurer Fee Reimbursement Receivables [Member]",
"label": "Health Insurer Fee Reimbursement Receivables [Member]",
"terseLabel": "Health insurer fee reimbursement receivables"
}
}
},
"localname": "HealthInsurerFeeReimbursementReceivablesMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
],
"xbrltype": "domainItemType"
},
"moh_HealthPlanContractTerm": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Health Plan, Contract Term",
"label": "Health Plan, Contract Term",
"terseLabel": "Contract term"
}
}
},
"localname": "HealthPlanContractTerm",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "durationItemType"
},
"moh_HealthPlansMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Health plans.",
"label": "Health Plans [Member]",
"terseLabel": "Health Plans"
}
}
},
"localname": "HealthPlansMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "domainItemType"
},
"moh_IncreaseDecreaseInHealthInsuranceFeeLiability": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Increase (Decrease) In Health Insurance Fee, Liability",
"label": "Increase (Decrease) In Health Insurance Fee, Liability",
"terseLabel": "Increase in HIF liabilities"
}
}
},
"localname": "IncreaseDecreaseInHealthInsuranceFeeLiability",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 9.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Increase (Decrease) in Medical Premium Liability Due to Agency",
"label": "Increase (Decrease) In Medical Premium Liability Due To Agency",
"terseLabel": "Amounts due government agencies"
}
}
},
"localname": "IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"moh_IncrementalTermLoanMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Incremental Term Loan",
"label": "Incremental Term Loan [Member]",
"terseLabel": "Incremental Term Loan"
}
}
},
"localname": "IncrementalTermLoanMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"moh_InvestmentsAverageMaturityPeriod": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Investments, Average Maturity Period",
"label": "Investments, Average Maturity Period",
"terseLabel": "Average maturity period"
}
}
},
"localname": "InvestmentsAverageMaturityPeriod",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "durationItemType"
},
"moh_InvestmentsMaturityPeriod": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Investments, Maturity Period",
"label": "Investments, Maturity Period",
"terseLabel": "Maturity period"
}
}
},
"localname": "InvestmentsMaturityPeriod",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "durationItemType"
},
"moh_LetterOfCreditSubFacilityMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Letter Of Credit Sub-Facility",
"label": "Letter Of Credit Sub-Facility [Member]",
"terseLabel": "Letter of credit sub-facility"
}
}
},
"localname": "LetterOfCreditSubFacilityMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandBenefitsPayableDetails": {
"order": 1.0,
"parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Paid (IBNP), Fee-for-service Claims, Amount",
"label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Paid (IBNP), Fee-for-service Claims, Amount",
"terseLabel": "Fee-for-service claims incurred but not paid (\u201cIBNP\u201d)"
}
}
},
"localname": "LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails": {
"order": 1.0,
"parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Long-Term Debt, Current Maturities, Net Of Unamortized Premium (Discount)",
"label": "Long-Term Debt, Current Maturities, Net Of Unamortized Premium (Discount)",
"terseLabel": "Debt net of unamortized discount"
}
}
},
"localname": "LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails": {
"order": 2.0,
"parentTag": "us-gaap_LongTermDebtNoncurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Long-Term Debt, Noncurrent, Net Of Unamortized Debt Discount",
"label": "Long-Term Debt, Noncurrent, Net Of Unamortized Debt Discount",
"terseLabel": "Debt net of unamortized debt discount"
}
}
},
"localname": "LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_MagellanCompleteCareMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Magellan Complete Care [Member]",
"label": "Magellan Complete Care [Member]",
"terseLabel": "Magellan complete care"
}
}
},
"localname": "MagellanCompleteCareMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "domainItemType"
},
"moh_MaineCommunityHealthOptionsv.UnitedStatesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Maine Community Health Options v. United States [Member]",
"label": "Maine Community Health Options v. United States [Member]",
"terseLabel": "Maine Community Health Options v. United States"
}
}
},
"localname": "MaineCommunityHealthOptionsv.UnitedStatesMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"moh_MaximumAvailableQualityIncentivePremiumCurrentYear": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Maximum available quality incentive premium current year.",
"label": "Maximum Available Quality Incentive Premium Current Year",
"terseLabel": "Maximum available quality incentive premium - current period"
}
}
},
"localname": "MaximumAvailableQualityIncentivePremiumCurrentYear",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_MedicalClaimsAndBenefitsPayable": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Medical Claims and Benefits Payable",
"label": "Medical Claims And Benefits Payable",
"terseLabel": "Non-risk provider payables"
}
}
},
"localname": "MedicalClaimsAndBenefitsPayable",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Medical Claims and Benefits Payable, Adjustments, Change in Provider",
"label": "Medical Claims And Benefits Payable, Adjustments, Change In Provider",
"terseLabel": "Change in non-risk and other provider payables"
}
}
},
"localname": "MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_MedicalClaimsAndBenefitsPayableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Medical claims and benefits payable.",
"label": "Medical Claims And Benefits Payable [Text Block]",
"terseLabel": "Medical Claims and Benefits Payable"
}
}
},
"localname": "MedicalClaimsAndBenefitsPayableTextBlock",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable"
],
"xbrltype": "textBlockItemType"
},
"moh_MedicalPremiumLiabilityDueToAgency": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Medical Premium Liability Due to Agency",
"label": "Medical Premium Liability Due To Agency",
"terseLabel": "Amounts due government agencies",
"totalLabel": "Amounts due government agencies"
}
}
},
"localname": "MedicalPremiumLiabilityDueToAgency",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS",
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
"order": 5.0,
"parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Medical Premiums Liability, Medical Care Costs Threshold",
"label": "Medical Premiums Liability, Medical Care Costs Threshold",
"terseLabel": "Minimum MLR and profit sharing"
}
}
},
"localname": "MedicalPremiumsLiabilityMedicalCareCostsThreshold",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_MunicipalSecuritiesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Municipal securities.",
"label": "Municipal Securities [Member]",
"terseLabel": "Municipal securities"
}
}
},
"localname": "MunicipalSecuritiesMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "domainItemType"
},
"moh_NumberOfMembersEligibleForTheHealthCarePrograms": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of members eligible for the health care programs.",
"label": "Number Of Members Eligible For The Health Care Programs",
"terseLabel": "Number of members eligible for the health care programs, approximately (in member)"
}
}
},
"localname": "NumberOfMembersEligibleForTheHealthCarePrograms",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "integerItemType"
},
"moh_OtherClaimsPayable": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandBenefitsPayableDetails": {
"order": 4.0,
"parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Other Claims Payable",
"label": "Other Claims Payable",
"terseLabel": "Other"
}
}
},
"localname": "OtherClaimsPayable",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_OtherMedicareProgram": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
"order": 4.0,
"parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Other Medicare Program",
"label": "Other Medicare Program",
"terseLabel": "Other"
}
}
},
"localname": "OtherMedicareProgram",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_OtherReceivablesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Other Receivables [Member]",
"label": "Other Receivables [Member]",
"terseLabel": "Other"
}
}
},
"localname": "OtherReceivablesMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
],
"xbrltype": "domainItemType"
},
"moh_OtherSecuritiesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Other Securities",
"label": "Other Securities [Member]",
"terseLabel": "Other"
}
}
},
"localname": "OtherSecuritiesMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "domainItemType"
},
"moh_PaymentsForMedicalCareCostsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Payments for medical care costs.",
"label": "Payments For Medical Care Costs [Abstract]",
"terseLabel": "Payments for medical care costs related to:"
}
}
},
"localname": "PaymentsForMedicalCareCostsAbstract",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "stringItemType"
},
"moh_PercentageOfAdditionalIncrementalRevenueEarned": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage of additional incremental revenue earned.",
"label": "Percentage Of Additional Incremental Revenue Earned",
"terseLabel": "Percentage of additional incremental revenue earned"
}
}
},
"localname": "PercentageOfAdditionalIncrementalRevenueEarned",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "percentItemType"
},
"moh_PharmacyClaimsPayable": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandBenefitsPayableDetails": {
"order": 2.0,
"parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Pharmacy Claims Payable",
"label": "Pharmacy Claims Payable",
"terseLabel": "Pharmacy payable"
}
}
},
"localname": "PharmacyClaimsPayable",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_PharmacyRebateReceivablesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Pharmacy Rebate Receivables [Member]",
"label": "Pharmacy Rebate Receivables [Member]",
"terseLabel": "Pharmacy rebate receivables"
}
}
},
"localname": "PharmacyRebateReceivablesMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
],
"xbrltype": "domainItemType"
},
"moh_PremiumTaxExpenses": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 3.0,
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "An assessment levied by a state government on the net premium income collected.",
"label": "Premium Tax Expenses",
"terseLabel": "Premium tax expenses"
}
}
},
"localname": "PremiumTaxExpenses",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"moh_QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Quality Incentive Premium Revenue As A Percentage Of Total Revenue",
"label": "Quality Incentive Premium Revenue As A Percentage Of Total Revenue",
"terseLabel": "Quality incentive premium revenue recognized as a percentage of total premium revenue"
}
}
},
"localname": "QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "percentItemType"
},
"moh_QualityIncentivePremiumRevenueRecognized": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Quality incentive premium revenue recognized.",
"label": "Quality Incentive Premium Revenue Recognized",
"totalLabel": "Total"
}
}
},
"localname": "QualityIncentivePremiumRevenueRecognized",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_QualityIncentivePremiumRevenueRecognizedAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Quality Incentive Premium Revenue Recognized [Abstract]",
"label": "Quality Incentive Premium Revenue Recognized [Abstract]",
"terseLabel": "Quality incentive premium revenue recognized in current period:"
}
}
},
"localname": "QualityIncentivePremiumRevenueRecognizedAbstract",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "stringItemType"
},
"moh_QualityIncentivePremiumRevenueRecognizedTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Quality incentive premium revenue recognized.",
"label": "Quality Incentive Premium Revenue Recognized [Table Text Block]",
"terseLabel": "Quality Incentive Premium Revenue Recognized"
}
}
},
"localname": "QualityIncentivePremiumRevenueRecognizedTableTextBlock",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables"
],
"xbrltype": "textBlockItemType"
},
"moh_ScheduleOfPremiumRevenueByHealthPlanTypeLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of premium revenue by health plan type.",
"label": "Schedule of Premium Revenue by Health Plan Type [Line Items]",
"terseLabel": "Schedule of Premium Revenue by Health Plan Type [Line Items]"
}
}
},
"localname": "ScheduleOfPremiumRevenueByHealthPlanTypeLineItems",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails",
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "stringItemType"
},
"moh_ScheduleOfPremiumRevenueByHealthPlanTypeTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of premium revenue by health plan type.",
"label": "Schedule of Premium Revenue by Health Plan Type [Table]",
"terseLabel": "Schedule Of Premium Revenue By Health Plan Type [Table]"
}
}
},
"localname": "ScheduleOfPremiumRevenueByHealthPlanTypeTable",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails",
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "stringItemType"
},
"moh_SeniorNotesDue2022Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Senior Notes Due 2022 [Member]",
"label": "Senior Notes Due 2022 [Member]",
"terseLabel": "5.375% Notes"
}
}
},
"localname": "SeniorNotesDue2022Member",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value",
"label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value",
"terseLabel": "Total granted"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails"
],
"xbrltype": "monetaryItemType"
},
"moh_SwinglineSubFacilityMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Swingline Sub Facility",
"label": "Swingline Sub Facility [Member]",
"terseLabel": "Swingline sub facility"
}
}
},
"localname": "SwinglineSubFacilityMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"moh_TermLoanMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Term Loan [Member]",
"label": "Term Loan [Member]",
"verboseLabel": "Term loan facility"
}
}
},
"localname": "TermLoanMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"moh_UnrecognizedCompensationForfeitedRate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Unrecognized compensation forfeited rate.",
"label": "Unrecognized Compensation Forfeited Rate",
"terseLabel": "Unrecognized compensation forfeiture rate"
}
}
},
"localname": "UnrecognizedCompensationForfeitedRate",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "percentItemType"
},
"moh_YourCareHealthPlanIncMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Your Care Health Plan Inc",
"label": "Your Care Health Plan Inc [Member]",
"terseLabel": "Your care health plan inc"
}
}
},
"localname": "YourCareHealthPlanIncMember",
"nsuri": "http://www.molinahealthcare.com/20200630",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "domainItemType"
},
"srt_ConsolidationItemsAxis": {
"auth_ref": [
"r152",
"r165",
"r166",
"r167",
"r168",
"r170",
"r172",
"r176"
],
"lang": {
"en-US": {
"role": {
"label": "Consolidation Items [Axis]",
"terseLabel": "Consolidation Items [Axis]"
}
}
},
"localname": "ConsolidationItemsAxis",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "stringItemType"
},
"srt_ConsolidationItemsDomain": {
"auth_ref": [
"r152",
"r165",
"r166",
"r167",
"r168",
"r170",
"r172",
"r176"
],
"lang": {
"en-US": {
"role": {
"label": "Consolidation Items [Domain]",
"terseLabel": "Consolidation Items [Domain]"
}
}
},
"localname": "ConsolidationItemsDomain",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "domainItemType"
},
"srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
"auth_ref": [
"r107",
"r112",
"r212",
"r301",
"r302",
"r303",
"r314",
"r315"
],
"lang": {
"en-US": {
"role": {
"label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
"terseLabel": "Adoption of new accounting standard"
}
}
},
"localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "domainItemType"
},
"srt_CumulativeEffectPeriodOfAdoptionAxis": {
"auth_ref": [
"r107",
"r112",
"r212",
"r301",
"r302",
"r303",
"r314",
"r315"
],
"lang": {
"en-US": {
"role": {
"label": "Cumulative Effect, Period of Adoption [Axis]",
"terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
}
}
},
"localname": "CumulativeEffectPeriodOfAdoptionAxis",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "stringItemType"
},
"srt_CumulativeEffectPeriodOfAdoptionDomain": {
"auth_ref": [
"r107",
"r112",
"r212",
"r301",
"r302",
"r303",
"r314",
"r315"
],
"lang": {
"en-US": {
"role": {
"label": "Cumulative Effect, Period of Adoption [Domain]",
"terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
}
}
},
"localname": "CumulativeEffectPeriodOfAdoptionDomain",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "domainItemType"
},
"srt_LitigationCaseAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Litigation Case [Axis]",
"terseLabel": "Litigation Case [Axis]"
}
}
},
"localname": "LitigationCaseAxis",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "stringItemType"
},
"srt_LitigationCaseTypeDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Litigation Case [Domain]",
"terseLabel": "Litigation Case [Domain]"
}
}
},
"localname": "LitigationCaseTypeDomain",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"srt_MaximumMember": {
"auth_ref": [
"r283",
"r285",
"r373",
"r374",
"r375",
"r376",
"r377",
"r378",
"r398",
"r447",
"r449"
],
"lang": {
"en-US": {
"role": {
"label": "Maximum [Member]",
"terseLabel": "Maximum"
}
}
},
"localname": "MaximumMember",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "domainItemType"
},
"srt_MinimumMember": {
"auth_ref": [
"r283",
"r285",
"r373",
"r374",
"r375",
"r376",
"r377",
"r378",
"r398",
"r447",
"r449"
],
"lang": {
"en-US": {
"role": {
"label": "Minimum [Member]",
"terseLabel": "Minimum"
}
}
},
"localname": "MinimumMember",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "domainItemType"
},
"srt_RangeAxis": {
"auth_ref": [
"r273",
"r283",
"r285",
"r373",
"r374",
"r375",
"r376",
"r377",
"r378",
"r398",
"r447",
"r449"
],
"lang": {
"en-US": {
"role": {
"label": "Statistical Measurement [Axis]",
"terseLabel": "Statistical Measurement [Axis]"
}
}
},
"localname": "RangeAxis",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "stringItemType"
},
"srt_RangeMember": {
"auth_ref": [
"r273",
"r283",
"r285",
"r373",
"r374",
"r375",
"r376",
"r377",
"r378",
"r398",
"r447",
"r449"
],
"lang": {
"en-US": {
"role": {
"label": "Statistical Measurement [Domain]",
"terseLabel": "Statistical Measurement [Domain]"
}
}
},
"localname": "RangeMember",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "domainItemType"
},
"srt_SegmentGeographicalDomain": {
"auth_ref": [
"r179",
"r180",
"r267",
"r269",
"r448",
"r464",
"r465",
"r466",
"r467",
"r468",
"r469",
"r470",
"r471"
],
"lang": {
"en-US": {
"role": {
"label": "Geographical [Domain]",
"terseLabel": "Geographical [Domain]"
}
}
},
"localname": "SegmentGeographicalDomain",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "domainItemType"
},
"srt_StatementGeographicalAxis": {
"auth_ref": [
"r179",
"r180",
"r267",
"r269",
"r448",
"r462",
"r464",
"r465",
"r466",
"r467",
"r468",
"r469",
"r470",
"r471",
"r472"
],
"lang": {
"en-US": {
"role": {
"label": "Geographical [Axis]",
"terseLabel": "Geographical [Axis]"
}
}
},
"localname": "StatementGeographicalAxis",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesQualityIncentivePremiumRevenueRecognizedDetails"
],
"xbrltype": "stringItemType"
},
"stpr_NY": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "NEW YORK",
"terseLabel": "New york"
}
}
},
"localname": "NY",
"nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_AccountingPoliciesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Accounting Policies [Abstract]",
"terseLabel": "Accounting Policies [Abstract]"
}
}
},
"localname": "AccountingPoliciesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_AccountsNotesAndLoansReceivableLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
"terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
}
}
},
"localname": "AccountsNotesAndLoansReceivableLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
"auth_ref": [
"r36"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of receivable.",
"label": "Receivable Type [Axis]",
"terseLabel": "Receivable Type [Axis]"
}
}
},
"localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
"auth_ref": [
"r26"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
"label": "Accounts Payable and Accrued Liabilities, Current",
"terseLabel": "Accounts payable, accrued liabilities and other"
}
}
},
"localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
"auth_ref": [
"r16",
"r47",
"r49",
"r50",
"r430",
"r454",
"r455"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 4.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
"label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
"terseLabel": "Accumulated other comprehensive income"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
"auth_ref": [
"r46",
"r50",
"r51",
"r104",
"r105",
"r106",
"r327",
"r450",
"r451"
],
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
"label": "AOCI Attributable to Parent [Member]",
"terseLabel": "Accumulated Other Comprehensive Income (Loss)"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "domainItemType"
},
"us-gaap_AdditionalPaidInCapitalCommonStock": {
"auth_ref": [
"r14"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 3.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
"label": "Additional Paid in Capital, Common Stock",
"terseLabel": "Additional paid-in capital"
}
}
},
"localname": "AdditionalPaidInCapitalCommonStock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdditionalPaidInCapitalMember": {
"auth_ref": [
"r104",
"r105",
"r106",
"r301",
"r302",
"r303"
],
"lang": {
"en-US": {
"role": {
"documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
"label": "Additional Paid-in Capital [Member]",
"terseLabel": "Additional Paid-in Capital"
}
}
},
"localname": "AdditionalPaidInCapitalMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "domainItemType"
},
"us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
"label": "Adjustments to Additional Paid in Capital, Other",
"terseLabel": "Termination of warrants"
}
}
},
"localname": "AdjustmentsToAdditionalPaidInCapitalOther",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
"terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
}
}
},
"localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "stringItemType"
},
"us-gaap_AllOtherSegmentsMember": {
"auth_ref": [
"r147",
"r165",
"r166",
"r167",
"r168",
"r170"
],
"lang": {
"en-US": {
"role": {
"documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
"label": "Other Segments [Member]",
"verboseLabel": "Other"
}
}
},
"localname": "AllOtherSegmentsMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_AssetBackedSecuritiesMember": {
"auth_ref": [
"r204",
"r274"
],
"lang": {
"en-US": {
"role": {
"documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
"label": "Asset-backed Securities [Member]",
"terseLabel": "Asset-backed securities"
}
}
},
"localname": "AssetBackedSecuritiesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_Assets": {
"auth_ref": [
"r97",
"r160",
"r167",
"r174",
"r211",
"r324",
"r328",
"r350",
"r402",
"r428"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets",
"totalLabel": "Total assets"
}
}
},
"localname": "Assets",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Assets [Abstract]",
"verboseLabel": "ASSETS"
}
}
},
"localname": "AssetsAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsCurrent": {
"auth_ref": [
"r5",
"r6",
"r38",
"r97",
"r211",
"r324",
"r328",
"r350"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 1.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets, Current",
"totalLabel": "Total current assets"
}
}
},
"localname": "AssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Assets, Current [Abstract]",
"terseLabel": "Current assets:"
}
}
},
"localname": "AssetsCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsFairValueDisclosure": {
"auth_ref": [
"r340"
],
"calculation": {
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets, Fair Value Disclosure",
"totalLabel": "Total"
}
}
},
"localname": "AssetsFairValueDisclosure",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
"auth_ref": [
"r193"
],
"calculation": {
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails": {
"order": 1.0,
"parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
"terseLabel": "Gross unrealized gains"
}
}
},
"localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
"auth_ref": [
"r194"
],
"calculation": {
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails": {
"order": 2.0,
"parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
"terseLabel": "Gross unrealized losses"
}
}
},
"localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
"auth_ref": [
"r191",
"r218"
],
"calculation": {
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Debt Securities, Available-for-sale, Amortized Cost",
"totalLabel": "Amortized Cost"
}
}
},
"localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
"terseLabel": "Unrealized Losses"
}
}
},
"localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
"auth_ref": [
"r198"
],
"calculation": {
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails": {
"order": 3.0,
"parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
"label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
"terseLabel": "Due after five years through ten years"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
"auth_ref": [
"r195",
"r198",
"r419"
],
"calculation": {
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails": {
"order": 3.0,
"parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
"label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
"terseLabel": "Due after five years through ten years"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
"auth_ref": [
"r197"
],
"calculation": {
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails": {
"order": 2.0,
"parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
"label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
"terseLabel": "Due after one year through five years"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
"auth_ref": [
"r195",
"r197",
"r418"
],
"calculation": {
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails": {
"order": 2.0,
"parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
"label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
"terseLabel": "Due after one year through five years"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
"auth_ref": [
"r199"
],
"calculation": {
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails": {
"order": 4.0,
"parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
"label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
"terseLabel": "Due after ten years"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
"auth_ref": [
"r195",
"r199",
"r420"
],
"calculation": {
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails": {
"order": 4.0,
"parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
"label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
"terseLabel": "Due after ten years"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
"terseLabel": "Amortized Cost"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]",
"terseLabel": "Estimated Fair Value"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
"auth_ref": [
"r196"
],
"calculation": {
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails": {
"order": 1.0,
"parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
"label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
"terseLabel": "Due in one year or less"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
"auth_ref": [
"r195",
"r196",
"r417"
],
"calculation": {
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails": {
"order": 1.0,
"parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
"label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
"terseLabel": "Due in one year or less"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
"auth_ref": [
"r200"
],
"calculation": {
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
"label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value",
"totalLabel": "Estimated Fair Value"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesofAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
"auth_ref": [
"r189",
"r192",
"r218",
"r406"
],
"calculation": {
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails": {
"order": 1.0,
"parentTag": "us-gaap_AssetsFairValueDisclosure",
"weight": 1.0
},
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails": {
"order": 3.0,
"parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Debt Securities, Available-for-sale",
"terseLabel": "Debt securities, available-for-sale",
"verboseLabel": "Estimated Fair Value"
}
}
},
"localname": "AvailableForSaleSecuritiesDebtSecurities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]",
"terseLabel": "Total Number\u00a0of Positions"
}
}
},
"localname": "AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AwardTypeAxis": {
"auth_ref": [
"r288",
"r300"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of award under share-based payment arrangement.",
"label": "Award Type [Axis]",
"terseLabel": "Award Type [Axis]"
}
}
},
"localname": "AwardTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails",
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BalanceSheetLocationAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by location on balance sheet (statement of financial position).",
"label": "Balance Sheet Location [Axis]",
"terseLabel": "Balance Sheet Location [Axis]"
}
}
},
"localname": "BalanceSheetLocationAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BalanceSheetLocationDomain": {
"auth_ref": [
"r332",
"r337"
],
"lang": {
"en-US": {
"role": {
"documentation": "Location in the balance sheet (statement of financial position).",
"label": "Balance Sheet Location [Domain]",
"terseLabel": "Balance Sheet Location [Domain]"
}
}
},
"localname": "BalanceSheetLocationDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_BusinessAcquisitionAcquireeDomain": {
"auth_ref": [
"r282",
"r284"
],
"lang": {
"en-US": {
"role": {
"documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
"label": "Business Acquisition, Acquiree [Domain]",
"terseLabel": "Business Acquisition, Acquiree [Domain]"
}
}
},
"localname": "BusinessAcquisitionAcquireeDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_BusinessAcquisitionAxis": {
"auth_ref": [
"r282",
"r284",
"r318",
"r319"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by business combination or series of individually immaterial business combinations.",
"label": "Business Acquisition [Axis]",
"terseLabel": "Business Acquisition [Axis]"
}
}
},
"localname": "BusinessAcquisitionAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
"auth_ref": [
"r348",
"r349"
],
"lang": {
"en-US": {
"role": {
"documentation": "Measured as reported on the statement of financial position (balance sheet).",
"label": "Reported Value Measurement [Member]",
"terseLabel": "Carrying Amount"
}
}
},
"localname": "CarryingReportedAmountFairValueDisclosureMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CashAndCashEquivalentsAtCarryingValue": {
"auth_ref": [
"r3",
"r23",
"r87"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 1.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
},
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashandCashEquivalentsDetails": {
"order": 1.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
"label": "Cash and Cash Equivalents, at Carrying Value",
"terseLabel": "Cash and cash equivalents"
}
}
},
"localname": "CashAndCashEquivalentsAtCarryingValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS",
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashandCashEquivalentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
"auth_ref": [
"r7",
"r88",
"r93"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
"label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
"terseLabel": "Cash and Cash Equivalents"
}
}
},
"localname": "CashAndCashEquivalentsPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
"auth_ref": [
"r81",
"r87",
"r92"
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashandCashEquivalentsDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
"periodEndLabel": "Cash, cash equivalents, and restricted cash and cash equivalents at end of period",
"periodStartLabel": "Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period",
"totalLabel": "Total cash, cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows"
}
}
},
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashandCashEquivalentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
"auth_ref": [
"r81",
"r351"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
"totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents"
}
}
},
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
"terseLabel": "Schedule of non-cash investing and financing activities:"
}
}
},
"localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "stringItemType"
},
"us-gaap_CertificatesOfDepositMember": {
"auth_ref": [
"r422"
],
"lang": {
"en-US": {
"role": {
"documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
"label": "Certificates of Deposit [Member]",
"terseLabel": "Certificates of deposit",
"verboseLabel": "Certificates of deposit"
}
}
},
"localname": "CertificatesOfDepositMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ClassOfStockLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Class of Stock [Line Items]",
"terseLabel": "Class of Stock [Line Items]"
}
}
},
"localname": "ClassOfStockLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ClassOfWarrantOrRightAxis": {
"auth_ref": [
"r255",
"r286"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of warrant or right issued.",
"label": "Class of Warrant or Right [Axis]",
"terseLabel": "Class of Warrant or Right [Axis]"
}
}
},
"localname": "ClassOfWarrantOrRightAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ClassOfWarrantOrRightDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
"label": "Class of Warrant or Right [Domain]",
"terseLabel": "Class of Warrant or Right [Domain]"
}
}
},
"localname": "ClassOfWarrantOrRightDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ClassOfWarrantOrRightOutstanding": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of warrants or rights outstanding.",
"label": "Class of Warrant or Right, Outstanding",
"terseLabel": "Warrants outstanding (in shares)"
}
}
},
"localname": "ClassOfWarrantOrRightOutstanding",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommercialMortgageBackedSecuritiesMember": {
"auth_ref": [
"r200",
"r274"
],
"lang": {
"en-US": {
"role": {
"documentation": "Securities collateralized by commercial real estate mortgage loans.",
"label": "Commercial Mortgage Backed Securities [Member]",
"terseLabel": "Mortgage-backed securities",
"verboseLabel": "Mortgage-backed securities"
}
}
},
"localname": "CommercialMortgageBackedSecuritiesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails",
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Commitments and Contingencies Disclosure [Abstract]",
"terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
}
}
},
"localname": "CommitmentsAndContingenciesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
"auth_ref": [
"r231",
"r232",
"r233",
"r237"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for commitments and contingencies.",
"label": "Commitments and Contingencies Disclosure [Text Block]",
"terseLabel": "Commitments and Contingencies"
}
}
},
"localname": "CommitmentsAndContingenciesDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CommitmentsandContingencies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CommonStockMember": {
"auth_ref": [
"r104",
"r105"
],
"lang": {
"en-US": {
"role": {
"documentation": "Stock that is subordinate to all other stock of the issuer.",
"label": "Common Stock [Member]",
"terseLabel": "Common Stock"
}
}
},
"localname": "CommonStockMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommonStockParOrStatedValuePerShare": {
"auth_ref": [
"r12"
],
"lang": {
"en-US": {
"role": {
"documentation": "Face amount or stated value per share of common stock.",
"label": "Common Stock, Par or Stated Value Per Share",
"terseLabel": "Common stock, par value (in dollars per share)"
}
}
},
"localname": "CommonStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
],
"xbrltype": "perShareItemType"
},
"us-gaap_CommonStockSharesAuthorized": {
"auth_ref": [
"r12"
],
"lang": {
"en-US": {
"role": {
"documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
"label": "Common Stock, Shares Authorized",
"terseLabel": "Common stock, shares authorized (in shares)"
}
}
},
"localname": "CommonStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesOutstanding": {
"auth_ref": [
"r12",
"r246"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
"label": "Common Stock, Shares, Outstanding",
"terseLabel": "Common stock, shares outstanding (in shares)"
}
}
},
"localname": "CommonStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockValueOutstanding": {
"auth_ref": [
"r12"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 1.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
"label": "Common Stock, Value, Outstanding",
"terseLabel": "Common stock, $0.001 par value, 150 million shares authorized; outstanding: 59 million shares at June\u00a030, 2020, and 62 million shares at December\u00a031, 2019"
}
}
},
"localname": "CommonStockValueOutstanding",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ComprehensiveIncomeNetOfTax": {
"auth_ref": [
"r54",
"r56",
"r57",
"r62",
"r409",
"r436"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
"label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
"totalLabel": "Comprehensive income"
}
}
},
"localname": "ComprehensiveIncomeNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ConcentrationRiskCreditRisk": {
"auth_ref": [
"r141",
"r424"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for credit risk.",
"label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
"terseLabel": "Concentrations of Credit Risk"
}
}
},
"localname": "ConcentrationRiskCreditRisk",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ContractWithCustomerLiabilityCurrent": {
"auth_ref": [
"r257",
"r258",
"r268"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
"label": "Contract with Customer, Liability, Current",
"terseLabel": "Deferred revenue"
}
}
},
"localname": "ContractWithCustomerLiabilityCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ConvertibleDebtMember": {
"auth_ref": [
"r239"
],
"lang": {
"en-US": {
"role": {
"documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
"label": "Convertible Debt [Member]",
"netLabel": "Convertible debt",
"terseLabel": "1.125% Convertible Notes, net of unamortized discount"
}
}
},
"localname": "ConvertibleDebtMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CorporateDebtSecuritiesMember": {
"auth_ref": [
"r274",
"r281",
"r459"
],
"lang": {
"en-US": {
"role": {
"documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
"label": "Corporate Debt Securities [Member]",
"terseLabel": "Corporate debt securities"
}
}
},
"localname": "CorporateDebtSecuritiesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails",
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CostOfGoodsAndServicesSold": {
"auth_ref": [
"r66",
"r399"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 1.0,
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
"label": "Cost of Goods and Services Sold",
"terseLabel": "Medical care costs"
}
}
},
"localname": "CostOfGoodsAndServicesSold",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CostsAndExpenses": {
"auth_ref": [
"r64"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 2.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Total costs of sales and operating expenses for the period.",
"label": "Costs and Expenses",
"negatedLabel": "Less: other operating expenses",
"totalLabel": "Total operating expenses"
}
}
},
"localname": "CostsAndExpenses",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CostsAndExpensesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Costs and Expenses [Abstract]",
"terseLabel": "Operating expenses:"
}
}
},
"localname": "CostsAndExpensesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "stringItemType"
},
"us-gaap_CreditFacilityAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
"label": "Credit Facility [Axis]",
"terseLabel": "Credit Facility [Axis]"
}
}
},
"localname": "CreditFacilityAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CreditFacilityDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
"label": "Credit Facility [Domain]",
"terseLabel": "Credit Facility [Domain]"
}
}
},
"localname": "CreditFacilityDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DebtCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Debt, Current [Abstract]",
"terseLabel": "Current portion of long-term debt:"
}
}
},
"localname": "DebtCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Debt Disclosure [Abstract]",
"terseLabel": "Debt Disclosure [Abstract]"
}
}
},
"localname": "DebtDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_DebtInstrumentAxis": {
"auth_ref": [
"r8",
"r9",
"r10",
"r403",
"r404",
"r427"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
"label": "Debt Instrument [Axis]",
"terseLabel": "Debt Instrument [Axis]"
}
}
},
"localname": "DebtInstrumentAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtInstrumentFaceAmount": {
"auth_ref": [
"r361",
"r363"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Face (par) amount of debt instrument at time of issuance.",
"label": "Debt Instrument, Face Amount",
"terseLabel": "Face amount"
}
}
},
"localname": "DebtInstrumentFaceAmount",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtInstrumentFairValue": {
"auth_ref": [
"r347"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
"label": "Debt Instrument, Fair Value Disclosure",
"terseLabel": "Fair value of debt"
}
}
},
"localname": "DebtInstrumentFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtInstrumentInterestRateStatedPercentage": {
"auth_ref": [
"r31"
],
"lang": {
"en-US": {
"role": {
"documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
"label": "Debt Instrument, Interest Rate, Stated Percentage",
"terseLabel": "Percentage of contractual interest rate on notes"
}
}
},
"localname": "DebtInstrumentInterestRateStatedPercentage",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_DebtInstrumentLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Debt Instrument [Line Items]",
"terseLabel": "Debt Instrument [Line Items]"
}
}
},
"localname": "DebtInstrumentLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtInstrumentNameDomain": {
"auth_ref": [
"r32"
],
"lang": {
"en-US": {
"role": {
"documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
"label": "Debt Instrument, Name [Domain]",
"terseLabel": "Debt Instrument, Name [Domain]"
}
}
},
"localname": "DebtInstrumentNameDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DebtInstrumentTable": {
"auth_ref": [
"r32",
"r99",
"r247",
"r250",
"r251",
"r252",
"r360",
"r361",
"r363",
"r423"
],
"lang": {
"en-US": {
"role": {
"documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
"label": "Schedule of Long-term Debt Instruments [Table]",
"terseLabel": "Schedule of Long-term Debt Instruments [Table]"
}
}
},
"localname": "DebtInstrumentTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtInstrumentTerm": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
"label": "Debt Instrument, Term",
"terseLabel": "Debt term"
}
}
},
"localname": "DebtInstrumentTerm",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
"auth_ref": [
"r206",
"r221",
"r224"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
"label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
"terseLabel": "In a Continuous Loss Position for 12 Months or More"
}
}
},
"localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
"auth_ref": [
"r206",
"r221"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
"label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
"terseLabel": "In a Continuous Loss Position for 12 Months or More"
}
}
},
"localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": {
"auth_ref": [
"r219"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
"label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions",
"terseLabel": "In a Continuous Loss Position for 12 Months or More"
}
}
},
"localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails"
],
"xbrltype": "integerItemType"
},
"us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
"auth_ref": [
"r206",
"r221",
"r224"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
"label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
"terseLabel": "In a Continuous Loss Position for Less than 12 Months"
}
}
},
"localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
"auth_ref": [
"r206",
"r221"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
"label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
"terseLabel": "In a Continuous Loss Position for Less than 12 Months"
}
}
},
"localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
"auth_ref": [
"r219"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
"label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
"terseLabel": "In a Continuous Loss Position for Less than 12 Months"
}
}
},
"localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails"
],
"xbrltype": "integerItemType"
},
"us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
"auth_ref": [
"r207"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Debt Securities, Available-for-sale, Realized Gain",
"terseLabel": "Gross realized investment gains"
}
}
},
"localname": "DebtSecuritiesAvailableForSaleRealizedGain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtSecuritiesAvailableForSaleTable": {
"auth_ref": [
"r209"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Debt Securities, Available-for-sale [Table]",
"terseLabel": "Debt Securities, Available-for-sale [Table]"
}
}
},
"localname": "DebtSecuritiesAvailableForSaleTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
"auth_ref": [
"r209"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
"label": "Debt Securities, Available-for-sale [Table Text Block]",
"terseLabel": "Available-for-Sale Investments in a Continuous Loss Position"
}
}
},
"localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]",
"terseLabel": "Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]"
}
}
},
"localname": "DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DeferredFinanceCostsNet": {
"auth_ref": [
"r24",
"r362"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
"label": "Debt Issuance Costs, Net",
"terseLabel": "Deferred issuance cost"
}
}
},
"localname": "DeferredFinanceCostsNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredFinanceCostsNoncurrentNet": {
"auth_ref": [
"r24",
"r362"
],
"calculation": {
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails": {
"order": 1.0,
"parentTag": "us-gaap_LongTermDebtNoncurrent",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
"label": "Debt Issuance Costs, Noncurrent, Net",
"negatedTerseLabel": "Deferred debt issuance costs"
}
}
},
"localname": "DeferredFinanceCostsNoncurrentNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredIncomeTaxAssetsNet": {
"auth_ref": [
"r307",
"r308"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 5.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
"label": "Deferred Income Tax Assets, Net",
"terseLabel": "Deferred income taxes"
}
}
},
"localname": "DeferredIncomeTaxAssetsNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DepreciationAndAmortization": {
"auth_ref": [
"r85",
"r226"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 5.0,
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
"label": "Depreciation, Depletion and Amortization, Nonproduction",
"terseLabel": "Depreciation and amortization"
}
}
},
"localname": "DepreciationAndAmortization",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DepreciationDepletionAndAmortization": {
"auth_ref": [
"r85",
"r155"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
"label": "Depreciation, Depletion and Amortization",
"terseLabel": "Depreciation and amortization"
}
}
},
"localname": "DepreciationDepletionAndAmortization",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeAssets": {
"auth_ref": [
"r41",
"r42",
"r347"
],
"calculation": {
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails": {
"order": 2.0,
"parentTag": "us-gaap_AssetsFairValueDisclosure",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
"label": "Derivative Asset",
"terseLabel": "Call option derivative asset"
}
}
},
"localname": "DerivativeAssets",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeContractTypeDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
"label": "Derivative Contract [Domain]",
"terseLabel": "Derivative Contract [Domain]"
}
}
},
"localname": "DerivativeContractTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DerivativeFairValueOfDerivativeAsset": {
"auth_ref": [
"r40",
"r43",
"r335",
"r380"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
"label": "Derivative Asset, Fair Value, Gross Asset",
"terseLabel": "Derivative assets"
}
}
},
"localname": "DerivativeFairValueOfDerivativeAsset",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeFairValueOfDerivativeLiability": {
"auth_ref": [
"r40",
"r43",
"r335",
"r380"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
"label": "Derivative Liability, Fair Value, Gross Liability",
"terseLabel": "Derivative liabilities"
}
}
},
"localname": "DerivativeFairValueOfDerivativeLiability",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeFinancialInstrumentsAssetsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "This element represents types of derivative financial instruments which are financial instruments or other contractual arrangements with all three of the following characteristics: (a) it has (1) one or more underlyings and (2) one or more notional amounts or payment provisions or both. Those terms determine the amount of the settlement or settlements, and, in some cases, whether or not a settlement is required; (b) it requires no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; and (c) its terms require or permit net settlement, it can readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position not substantially different from net settlement. Notwithstanding the above characteristics, loan commitments that relate to the origination of mortgage loans that will be held for sale are accounted for as derivative instruments by the issuer of the loan commitment (that is, the potential lender).",
"label": "Derivative Financial Instruments, Assets [Member]",
"terseLabel": "Call option derivative asset"
}
}
},
"localname": "DerivativeFinancialInstrumentsAssetsMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DerivativeGainLossOnDerivativeNet": {
"auth_ref": [
"r334"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
"label": "Derivative, Gain (Loss) on Derivative, Net",
"terseLabel": "Change in fair value of derivatives, net"
}
}
},
"localname": "DerivativeGainLossOnDerivativeNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeInstrumentRiskAxis": {
"auth_ref": [
"r333",
"r336",
"r338",
"r339"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of derivative contract.",
"label": "Derivative Instrument [Axis]",
"terseLabel": "Derivative Instrument [Axis]"
}
}
},
"localname": "DerivativeInstrumentRiskAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeLiabilities": {
"auth_ref": [
"r41",
"r42",
"r347"
],
"calculation": {
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
"label": "Derivative Liability",
"verboseLabel": "Conversion option derivative liability"
}
}
},
"localname": "DerivativeLiabilities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DilutiveSecuritiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
"terseLabel": "Effect of dilutive securities:"
}
}
},
"localname": "DilutiveSecuritiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Earnings Per Share [Abstract]",
"terseLabel": "Earnings Per Share [Abstract]"
}
}
},
"localname": "EarningsPerShareAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareBasic": {
"auth_ref": [
"r63",
"r110",
"r111",
"r112",
"r113",
"r114",
"r118",
"r121",
"r127",
"r128",
"r129",
"r133",
"r134",
"r410",
"r437"
],
"lang": {
"en-US": {
"role": {
"documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
"label": "Earnings Per Share, Basic",
"verboseLabel": "Basic (in dollars per share)"
}
}
},
"localname": "EarningsPerShareBasic",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Earnings Per Share, Basic and Diluted [Abstract]",
"terseLabel": "Net income per share:"
}
}
},
"localname": "EarningsPerShareBasicAndDilutedAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareDiluted": {
"auth_ref": [
"r63",
"r110",
"r111",
"r112",
"r113",
"r114",
"r121",
"r127",
"r128",
"r129",
"r133",
"r134",
"r410",
"r437"
],
"lang": {
"en-US": {
"role": {
"documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
"label": "Earnings Per Share, Diluted",
"terseLabel": "Diluted (in dollars per share)"
}
}
},
"localname": "EarningsPerShareDiluted",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerShareTextBlock": {
"auth_ref": [
"r130",
"r131",
"r132",
"r135"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for earnings per share.",
"label": "Earnings Per Share [Text Block]",
"terseLabel": "Net Income per Share"
}
}
},
"localname": "EarningsPerShareTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/NetIncomeperShare"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_EmbeddedDerivativeFinancialInstrumentsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Derivative instrument embedded in host contract.",
"label": "Embedded Derivative Financial Instruments [Member]",
"netLabel": "Conversion option",
"verboseLabel": "Conversion option derivative liability"
}
}
},
"localname": "EmbeddedDerivativeFinancialInstrumentsMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
"auth_ref": [
"r299"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
"label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
"terseLabel": "Unrecognized compensation expense"
}
}
},
"localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
"auth_ref": [
"r299"
],
"lang": {
"en-US": {
"role": {
"documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
"label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
"verboseLabel": "Weighted average period for recognition"
}
}
},
"localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_EmployeeStockOptionMember": {
"auth_ref": [
"r298"
],
"lang": {
"en-US": {
"role": {
"documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
"label": "Share-based Payment Arrangement, Option [Member]",
"terseLabel": "Employee stock option"
}
}
},
"localname": "EmployeeStockOptionMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_EquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Equity [Abstract]",
"terseLabel": "Equity [Abstract]"
}
}
},
"localname": "EquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_EquityComponentDomain": {
"auth_ref": [
"r104",
"r105",
"r106",
"r109",
"r115",
"r117",
"r136",
"r212",
"r246",
"r253",
"r301",
"r302",
"r303",
"r314",
"r315",
"r352",
"r353",
"r354",
"r355",
"r356",
"r357",
"r450",
"r451",
"r452"
],
"lang": {
"en-US": {
"role": {
"documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
"label": "Equity Component [Domain]",
"terseLabel": "Equity Component [Domain]"
}
}
},
"localname": "EquityComponentDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
"auth_ref": [
"r347"
],
"lang": {
"en-US": {
"role": {
"documentation": "Measured as an estimate of fair value.",
"label": "Estimate of Fair Value Measurement [Member]",
"verboseLabel": "Fair Value"
}
}
},
"localname": "EstimateOfFairValueFairValueDisclosureMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
"terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
}
}
},
"localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
"auth_ref": [
"r340",
"r341",
"r342",
"r344"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
"label": "Fair Value, Recurring and Nonrecurring [Table]",
"terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
}
}
},
"localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
"auth_ref": [
"r340",
"r341"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
"label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
"terseLabel": "Fair Value of Assets Measured on Recurring Basis"
}
}
},
"localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
"terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
}
}
},
"localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueByBalanceSheetGroupingTable": {
"auth_ref": [
"r340",
"r348",
"r349"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
"label": "Fair Value, by Balance Sheet Grouping [Table]",
"terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
}
}
},
"localname": "FairValueByBalanceSheetGroupingTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
"auth_ref": [
"r340",
"r348"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
"label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
"terseLabel": "Fair Value, by Balance Sheet Grouping"
}
}
},
"localname": "FairValueByBalanceSheetGroupingTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_FairValueByFairValueHierarchyLevelAxis": {
"auth_ref": [
"r274",
"r275",
"r276",
"r277",
"r278",
"r279",
"r280",
"r281",
"r341",
"r370",
"r371",
"r372"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
"label": "Fair Value Hierarchy and NAV [Axis]",
"terseLabel": "Fair Value Hierarchy and NAV [Axis]"
}
}
},
"localname": "FairValueByFairValueHierarchyLevelAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueByMeasurementBasisAxis": {
"auth_ref": [
"r340",
"r345"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by measurement basis.",
"label": "Measurement Basis [Axis]",
"terseLabel": "Measurement Basis [Axis]"
}
}
},
"localname": "FairValueByMeasurementBasisAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueDisclosureItemAmountsDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
"label": "Fair Value Measurement [Domain]",
"terseLabel": "Fair Value Measurement [Domain]"
}
}
},
"localname": "FairValueDisclosureItemAmountsDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueDisclosuresAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Fair Value Disclosures [Abstract]",
"terseLabel": "Fair Value Disclosures [Abstract]"
}
}
},
"localname": "FairValueDisclosuresAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_FairValueDisclosuresTextBlock": {
"auth_ref": [
"r343"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
"label": "Fair Value Disclosures [Text Block]",
"terseLabel": "Fair Value Measurements"
}
}
},
"localname": "FairValueDisclosuresTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurements"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_FairValueInputsLevel1Member": {
"auth_ref": [
"r274",
"r275",
"r280",
"r281",
"r341",
"r370"
],
"lang": {
"en-US": {
"role": {
"documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
"label": "Fair Value, Inputs, Level 1 [Member]",
"terseLabel": "(Level 1)"
}
}
},
"localname": "FairValueInputsLevel1Member",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueInputsLevel2Member": {
"auth_ref": [
"r274",
"r275",
"r280",
"r281",
"r341",
"r371"
],
"lang": {
"en-US": {
"role": {
"documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
"label": "Fair Value, Inputs, Level 2 [Member]",
"terseLabel": "(Level 2)"
}
}
},
"localname": "FairValueInputsLevel2Member",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueInputsLevel3Member": {
"auth_ref": [
"r274",
"r275",
"r276",
"r277",
"r278",
"r279",
"r280",
"r281",
"r341",
"r372"
],
"lang": {
"en-US": {
"role": {
"documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
"label": "Fair Value, Inputs, Level 3 [Member]",
"terseLabel": "(Level 3)"
}
}
},
"localname": "FairValueInputsLevel3Member",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
"auth_ref": [
"r274",
"r275",
"r276",
"r277",
"r278",
"r279",
"r280",
"r281",
"r370",
"r371",
"r372"
],
"lang": {
"en-US": {
"role": {
"documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
"label": "Fair Value Hierarchy and NAV [Domain]",
"terseLabel": "Fair Value Hierarchy and NAV [Domain]"
}
}
},
"localname": "FairValueMeasurementsFairValueHierarchyDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FinanceLeaseLiabilityNoncurrent": {
"auth_ref": [
"r364"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 3.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
"label": "Finance Lease, Liability, Noncurrent",
"terseLabel": "Finance lease liabilities"
}
}
},
"localname": "FinanceLeaseLiabilityNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FinancialInstrumentAxis": {
"auth_ref": [
"r204",
"r205",
"r213",
"r214",
"r215",
"r216",
"r217",
"r220",
"r222",
"r223",
"r224",
"r367",
"r368",
"r369",
"r370",
"r371",
"r372",
"r373",
"r374",
"r375",
"r376",
"r377",
"r378",
"r379",
"r381",
"r382",
"r383",
"r384",
"r385",
"r386",
"r387",
"r388",
"r389",
"r390",
"r391",
"r392",
"r393",
"r394",
"r395",
"r396",
"r397"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of financial instrument.",
"label": "Financial Instrument [Axis]",
"terseLabel": "Financial Instrument [Axis]"
}
}
},
"localname": "FinancialInstrumentAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails",
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_GainsLossesOnExtinguishmentOfDebt": {
"auth_ref": [
"r85",
"r240",
"r241"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
"label": "Gain (Loss) on Extinguishment of Debt",
"negatedTerseLabel": "Loss (gain) on debt repayment",
"terseLabel": "Gain (loss) on debt repayment"
}
}
},
"localname": "GainsLossesOnExtinguishmentOfDebt",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GeneralAndAdministrativeExpense": {
"auth_ref": [
"r68"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 2.0,
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
"label": "General and Administrative Expense",
"verboseLabel": "General and administrative expenses"
}
}
},
"localname": "GeneralAndAdministrativeExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GrossProfit": {
"auth_ref": [
"r65",
"r97",
"r160",
"r166",
"r170",
"r173",
"r176",
"r211",
"r350"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
"label": "Gross Profit",
"terseLabel": "Gross margin"
}
}
},
"localname": "GrossProfit",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_HeldToMaturitySecurities": {
"auth_ref": [
"r189",
"r201",
"r406"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity).",
"label": "Debt Securities, Held-to-maturity",
"terseLabel": "Debt securities held to maturity"
}
}
},
"localname": "HeldToMaturitySecurities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount": {
"auth_ref": [
"r203",
"r416"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
"label": "Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
"terseLabel": "Held-to-maturity, over one year to five years, amortized cost"
}
}
},
"localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount": {
"auth_ref": [
"r202",
"r415"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
"label": "Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
"netLabel": "Held-to-maturity, within one year, amortized cost"
}
}
},
"localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
"auth_ref": [
"r101",
"r160",
"r166",
"r170",
"r173",
"r176"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 1.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
"label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
"terseLabel": "Income before income tax expense",
"totalLabel": "Income before income tax expense"
}
}
},
"localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeStatementAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Income Statement [Abstract]",
"terseLabel": "Income Statement [Abstract]"
}
}
},
"localname": "IncomeStatementAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_IncomeTaxExpenseBenefit": {
"auth_ref": [
"r98",
"r116",
"r117",
"r158",
"r309",
"r316",
"r317",
"r439"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 2.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
"label": "Income Tax Expense (Benefit)",
"terseLabel": "Income tax expense"
}
}
},
"localname": "IncomeTaxExpenseBenefit",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeTaxPolicyTextBlock": {
"auth_ref": [
"r58",
"r93",
"r305",
"r306",
"r310",
"r311",
"r312",
"r313",
"r463"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
"label": "Income Tax, Policy [Policy Text Block]",
"terseLabel": "Income Taxes"
}
}
},
"localname": "IncomeTaxPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
"auth_ref": [
"r84"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 10.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
"label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
"terseLabel": "Accounts payable, accrued liabilities and other"
}
}
},
"localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
"auth_ref": [
"r84"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 12.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
"label": "Increase (Decrease) in Income Taxes Payable",
"terseLabel": "Income taxes"
}
}
},
"localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
"auth_ref": [
"r84"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 11.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
"label": "Increase (Decrease) in Contract with Customer, Liability",
"terseLabel": "Deferred revenue"
}
}
},
"localname": "IncreaseDecreaseInContractWithCustomerLiability",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
"auth_ref": [
"r84"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
"label": "Increase (Decrease) in Deferred Income Taxes",
"negatedLabel": "Deferred income taxes"
}
}
},
"localname": "IncreaseDecreaseInDeferredIncomeTaxes",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": {
"auth_ref": [
"r84"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 8.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) in health care insurance liability balances during the period.",
"label": "Increase (Decrease) in Health Care Insurance Liabilities",
"terseLabel": "Medical claims and benefits payable"
}
}
},
"localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Increase (Decrease) in Operating Capital [Abstract]",
"terseLabel": "Changes in operating assets and liabilities:"
}
}
},
"localname": "IncreaseDecreaseInOperatingCapitalAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncreaseDecreaseInPremiumsReceivable": {
"auth_ref": [
"r84"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The change in the premium receivable balance on the balance sheet.",
"label": "Increase (Decrease) in Premiums Receivable",
"negatedTerseLabel": "Reduction in premiums"
}
}
},
"localname": "IncreaseDecreaseInPremiumsReceivable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
"auth_ref": [
"r84"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 7.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
"label": "Increase (Decrease) in Prepaid Expense and Other Assets",
"negatedLabel": "Prepaid expenses and other current assets"
}
}
},
"localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInReceivables": {
"auth_ref": [
"r84"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 6.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
"label": "Increase (Decrease) in Receivables",
"negatedLabel": "Receivables"
}
}
},
"localname": "IncreaseDecreaseInReceivables",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
"terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
}
}
},
"localname": "IncreaseDecreaseInStockholdersEquityRollForward",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
"auth_ref": [
"r122",
"r123",
"r124",
"r129"
],
"calculation": {
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails": {
"order": 2.0,
"parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
"label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
"terseLabel": "Warrants (in shares)"
}
}
},
"localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
"auth_ref": [
"r122",
"r123",
"r125",
"r129"
],
"calculation": {
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails": {
"order": 3.0,
"parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
"label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
"terseLabel": "Stock-based compensation (in shares)"
}
}
},
"localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_IntangibleAssetsNetIncludingGoodwill": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 3.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
"label": "Intangible Assets, Net (Including Goodwill)",
"terseLabel": "Goodwill and intangible assets, net"
}
}
},
"localname": "IntangibleAssetsNetIncludingGoodwill",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestAndDividendIncomeOperating": {
"auth_ref": [
"r411"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 4.0,
"parentTag": "us-gaap_Revenues",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.",
"label": "Interest and Dividend Income, Operating",
"terseLabel": "Investment income and other revenue"
}
}
},
"localname": "InterestAndDividendIncomeOperating",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestExpense": {
"auth_ref": [
"r59",
"r154",
"r359",
"r362",
"r412"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 1.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
"label": "Interest Expense",
"terseLabel": "Interest expense"
}
}
},
"localname": "InterestExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestReceivable": {
"auth_ref": [
"r37"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
"label": "Interest Receivable",
"terseLabel": "Interest receivable"
}
}
},
"localname": "InterestReceivable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InvestmentPolicyTextBlock": {
"auth_ref": [
"r210",
"r438"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for investment in financial asset.",
"label": "Investment, Policy [Policy Text Block]",
"terseLabel": "Investments"
}
}
},
"localname": "InvestmentPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
"label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
"terseLabel": "Contractual Maturities of Investments"
}
}
},
"localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Investments, Debt and Equity Securities [Abstract]",
"terseLabel": "Investments, Debt and Equity Securities [Abstract]"
}
}
},
"localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
"auth_ref": [
"r209",
"r400",
"r421",
"r461"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for investments in certain debt and equity securities.",
"label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
"terseLabel": "Investments"
}
}
},
"localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/Investments"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_Liabilities": {
"auth_ref": [
"r27",
"r97",
"r168",
"r211",
"r325",
"r328",
"r329",
"r350"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
"label": "Liabilities",
"totalLabel": "Total liabilities"
}
}
},
"localname": "Liabilities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquity": {
"auth_ref": [
"r19",
"r97",
"r211",
"r350",
"r405",
"r432"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
"label": "Liabilities and Equity",
"totalLabel": "Total liabilities and stockholders\u2019 equity"
}
}
},
"localname": "LiabilitiesAndStockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Liabilities and Equity [Abstract]",
"terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
}
}
},
"localname": "LiabilitiesAndStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilitiesCurrent": {
"auth_ref": [
"r30",
"r97",
"r211",
"r325",
"r328",
"r329",
"r350"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 1.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
"label": "Liabilities, Current",
"terseLabel": "Total current liabilities"
}
}
},
"localname": "LiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Liabilities, Current [Abstract]",
"terseLabel": "Current liabilities:"
}
}
},
"localname": "LiabilitiesCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilitiesFairValueDisclosure": {
"auth_ref": [
"r340"
],
"calculation": {
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of financial and nonfinancial obligations.",
"label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
"totalLabel": "Total liabilities"
}
}
},
"localname": "LiabilitiesFairValueDisclosure",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
"auth_ref": [
"r441",
"r444"
],
"calculation": {
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandBenefitsPayableDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
"label": "Liability for Claims and Claims Adjustment Expense",
"periodEndLabel": "Medical claims and benefits payable, ending balance",
"periodStartLabel": "Medical claims and benefits payable, beginning balance",
"terseLabel": "Medical claims and benefits payable",
"totalLabel": "Total"
}
}
},
"localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS",
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails",
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
"auth_ref": [
"r443"
],
"calculation": {
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails": {
"order": 1.0,
"parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
"label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
"terseLabel": "Current year"
}
}
},
"localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
"auth_ref": [
"r443"
],
"calculation": {
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails": {
"order": 2.0,
"parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
"label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
"terseLabel": "Prior years"
}
}
},
"localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
"auth_ref": [
"r442"
],
"calculation": {
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
"label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
"totalLabel": "Total medical care costs"
}
}
},
"localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
"terseLabel": "Insurance Claims"
}
}
},
"localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_LineOfCredit": {
"auth_ref": [
"r10",
"r404",
"r427"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
"label": "Long-term Line of Credit",
"terseLabel": "Amount outstanding under letter of credit"
}
}
},
"localname": "LineOfCredit",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
"auth_ref": [
"r25"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
"label": "Line of Credit Facility, Maximum Borrowing Capacity",
"terseLabel": "Maximum borrowing capacity"
}
}
},
"localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LineOfCreditMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
"label": "Line of Credit [Member]",
"terseLabel": "Term loan facility"
}
}
},
"localname": "LineOfCreditMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
"auth_ref": [
"r29"
],
"calculation": {
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of long-term debt and lease obligation, classified as current.",
"label": "Long-term Debt and Lease Obligation, Current",
"totalLabel": "Current portion of long-term debt"
}
}
},
"localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LongTermDebtNoncurrent": {
"auth_ref": [
"r32"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 2.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
},
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
"label": "Long-term Debt, Excluding Current Maturities",
"terseLabel": "Long-term debt",
"totalLabel": "Long-term debt"
}
}
},
"localname": "LongTermDebtNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LongTermDebtNoncurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Long-term Debt, Excluding Current Maturities [Abstract]",
"terseLabel": "Non-current portion of long-term debt:"
}
}
},
"localname": "LongTermDebtNoncurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_LongTermDebtTextBlock": {
"auth_ref": [
"r242"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for long-term debt.",
"label": "Long-term Debt [Text Block]",
"terseLabel": "Debt"
}
}
},
"localname": "LongTermDebtTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/Debt"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_LongtermDebtTypeAxis": {
"auth_ref": [
"r32"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of long-term debt.",
"label": "Long-term Debt, Type [Axis]",
"terseLabel": "Long-term Debt, Type [Axis]"
}
}
},
"localname": "LongtermDebtTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_LongtermDebtTypeDomain": {
"auth_ref": [
"r32",
"r238"
],
"lang": {
"en-US": {
"role": {
"documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
"label": "Long-term Debt, Type [Domain]",
"terseLabel": "Long-term Debt, Type [Domain]"
}
}
},
"localname": "LongtermDebtTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_LossContingencyDamagesAwardedValue": {
"auth_ref": [
"r234",
"r235",
"r236"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
"label": "Loss Contingency, Damages Awarded, Value",
"verboseLabel": "Summary judgement"
}
}
},
"localname": "LossContingencyDamagesAwardedValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_MarketableSecuritiesCurrent": {
"auth_ref": [
"r4",
"r28"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 2.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in marketable security, classified as current.",
"label": "Marketable Securities, Current",
"terseLabel": "Investments"
}
}
},
"localname": "MarketableSecuritiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_MaterialReconcilingItemsMember": {
"auth_ref": [
"r170"
],
"lang": {
"en-US": {
"role": {
"documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
"label": "Segment Reconciling Items [Member]",
"terseLabel": "Other operating"
}
}
},
"localname": "MaterialReconcilingItemsMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivities": {
"auth_ref": [
"r81"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 3.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
"label": "Net Cash Provided by (Used in) Financing Activities",
"totalLabel": "Net cash provided by (used in) financing activities"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
"terseLabel": "Financing activities:"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivities": {
"auth_ref": [
"r81"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 2.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
"label": "Net Cash Provided by (Used in) Investing Activities",
"totalLabel": "Net cash provided by (used in) investing activities"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
"terseLabel": "Investing activities:"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivities": {
"auth_ref": [
"r81",
"r83",
"r86"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 1.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
"label": "Net Cash Provided by (Used in) Operating Activities",
"totalLabel": "Net cash provided by operating activities"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
"terseLabel": "Operating activities:"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetIncomeLoss": {
"auth_ref": [
"r1",
"r52",
"r55",
"r61",
"r86",
"r97",
"r108",
"r110",
"r111",
"r112",
"r113",
"r116",
"r117",
"r126",
"r160",
"r166",
"r170",
"r173",
"r176",
"r211",
"r350",
"r408",
"r435"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 13.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
},
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
"order": 2.0,
"parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
"weight": 1.0
},
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
"label": "Net Income (Loss) Attributable to Parent",
"totalLabel": "Net income",
"verboseLabel": "Net income"
}
}
},
"localname": "NetIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
"terseLabel": "Numerator:"
}
}
},
"localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
"label": "New Accounting Pronouncements, Policy [Policy Text Block]",
"terseLabel": "Recent Accounting Pronouncements Adopted and Not Yet Adopted"
}
}
},
"localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_NonoperatingIncomeExpense": {
"auth_ref": [
"r69"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 2.0,
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
"label": "Nonoperating Income (Expense)",
"negatedTerseLabel": "Other expenses, net",
"negatedTotalLabel": "Total other expenses, net"
}
}
},
"localname": "NonoperatingIncomeExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NonoperatingIncomeExpenseAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Nonoperating Income (Expense) [Abstract]",
"terseLabel": "Other expenses, net:"
}
}
},
"localname": "NonoperatingIncomeExpenseAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "stringItemType"
},
"us-gaap_NumberOfReportableSegments": {
"auth_ref": [
"r148"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
"label": "Number of Reportable Segments",
"terseLabel": "Number of reportable segments (in segment)"
}
}
},
"localname": "NumberOfReportableSegments",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"http://www.molinahealthcare.com/role/SegmentsNarrativeDetails"
],
"xbrltype": "integerItemType"
},
"us-gaap_NumberOfStatesInWhichEntityOperates": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of states the entity operates in as of the balance sheet date.",
"label": "Number of States in which Entity Operates",
"terseLabel": "Number of states in which entity operates (in state)"
}
}
},
"localname": "NumberOfStatesInWhichEntityOperates",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "integerItemType"
},
"us-gaap_OperatingIncomeLoss": {
"auth_ref": [
"r160",
"r166",
"r170",
"r173",
"r176"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 1.0,
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The net result for the period of deducting operating expenses from operating revenues.",
"label": "Operating Income (Loss)",
"terseLabel": "Operating income",
"totalLabel": "Operating income"
}
}
},
"localname": "OperatingIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingSegmentsMember": {
"auth_ref": [
"r165",
"r166",
"r167",
"r168",
"r170",
"r176"
],
"lang": {
"en-US": {
"role": {
"documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
"label": "Operating Segments [Member]",
"terseLabel": "Operating segments"
}
}
},
"localname": "OperatingSegmentsMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
"terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
}
}
},
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
"auth_ref": [
"r2",
"r331"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
"label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
"terseLabel": "Organization and Basis of Presentation"
}
}
},
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_OtherAssetsNoncurrent": {
"auth_ref": [
"r24"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 6.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of noncurrent assets classified as other.",
"label": "Other Assets, Noncurrent",
"terseLabel": "Other assets"
}
}
},
"localname": "OtherAssetsNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
"auth_ref": [
"r53",
"r56",
"r322",
"r323",
"r326"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
"order": 1.0,
"parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
"label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
"terseLabel": "Other comprehensive income (loss), net",
"totalLabel": "Other comprehensive income, net of tax"
}
}
},
"localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
"terseLabel": "Other comprehensive income:"
}
}
},
"localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
],
"xbrltype": "stringItemType"
},
"us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": {
"auth_ref": [
"r44",
"r47",
"r208"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
"order": 1.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
"label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax",
"terseLabel": "Unrealized investment income"
}
}
},
"localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
"auth_ref": [
"r45",
"r48"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
"order": 2.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
"label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
"terseLabel": "Less: effect of income taxes"
}
}
},
"localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherCostAndExpenseOperating": {
"auth_ref": [
"r67"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 6.0,
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.",
"label": "Other Cost and Expense, Operating",
"terseLabel": "Other"
}
}
},
"localname": "OtherCostAndExpenseOperating",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherLiabilitiesDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Other Liabilities Disclosure [Abstract]",
"terseLabel": "Other Liabilities Disclosure [Abstract]"
}
}
},
"localname": "OtherLiabilitiesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_OtherLiabilitiesNoncurrent": {
"auth_ref": [
"r33"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 4.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
"label": "Other Liabilities, Noncurrent",
"terseLabel": "Other long-term liabilities"
}
}
},
"localname": "OtherLiabilitiesNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherNonoperatingIncomeExpense": {
"auth_ref": [
"r70"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 2.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
"label": "Other Nonoperating Income (Expense)",
"negatedLabel": "Other expense (income), net"
}
}
},
"localname": "OtherNonoperatingIncomeExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherOperatingActivitiesCashFlowStatement": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
"label": "Other Operating Activities, Cash Flow Statement",
"terseLabel": "Other, net"
}
}
},
"localname": "OtherOperatingActivitiesCashFlowStatement",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
"auth_ref": [
"r82",
"r443"
],
"calculation": {
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
"label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
"totalLabel": "Total paid"
}
}
},
"localname": "PaymentsForLossesAndLossAdjustmentExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
"auth_ref": [
"r72",
"r75",
"r102"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
"label": "Payments for (Proceeds from) Other Investing Activities",
"negatedLabel": "Other, net"
}
}
},
"localname": "PaymentsForProceedsFromOtherInvestingActivities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsForRepurchaseOfCommonStock": {
"auth_ref": [
"r78"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 8.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow to reacquire common stock during the period.",
"label": "Payments for Repurchase of Common Stock",
"negatedLabel": "Common stock purchases",
"verboseLabel": "Common stock purchases"
}
}
},
"localname": "PaymentsForRepurchaseOfCommonStock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsForRepurchaseOfWarrants": {
"auth_ref": [
"r78"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt.",
"label": "Payments for Repurchase of Warrants",
"negatedTerseLabel": "Cash paid for partial termination of warrants",
"verboseLabel": "Cash paid for partial termination of 1.125% Warrants"
}
}
},
"localname": "PaymentsForRepurchaseOfWarrants",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
"auth_ref": [
"r73"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
"label": "Payments to Acquire Businesses, Net of Cash Acquired",
"terseLabel": "Net purchase price"
}
}
},
"localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireMarketableSecurities": {
"auth_ref": [
"r190"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow for purchase of marketable security.",
"label": "Payments to Acquire Marketable Securities",
"negatedLabel": "Purchases of investments"
}
}
},
"localname": "PaymentsToAcquireMarketableSecurities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireProductiveAssets": {
"auth_ref": [
"r74"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
"label": "Payments to Acquire Productive Assets",
"terseLabel": "Purchase price of assets"
}
}
},
"localname": "PaymentsToAcquireProductiveAssets",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
"auth_ref": [
"r74"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
"label": "Payments to Acquire Property, Plant, and Equipment",
"negatedLabel": "Purchases of property, equipment and capitalized software"
}
}
},
"localname": "PaymentsToAcquirePropertyPlantAndEquipment",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PortionAtFairValueFairValueDisclosureMember": {
"auth_ref": [
"r346"
],
"lang": {
"en-US": {
"role": {
"documentation": "Measured at fair value for financial reporting purposes.",
"label": "Portion at Fair Value Measurement [Member]",
"terseLabel": "Portion at fair value measurement"
}
}
},
"localname": "PortionAtFairValueFairValueDisclosureMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PreferredStockParOrStatedValuePerShare": {
"auth_ref": [
"r11"
],
"lang": {
"en-US": {
"role": {
"documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
"label": "Preferred Stock, Par or Stated Value Per Share",
"terseLabel": "Preferred stock, par value (in dollars per share)"
}
}
},
"localname": "PreferredStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
],
"xbrltype": "perShareItemType"
},
"us-gaap_PreferredStockSharesAuthorized": {
"auth_ref": [
"r11"
],
"lang": {
"en-US": {
"role": {
"documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
"label": "Preferred Stock, Shares Authorized",
"terseLabel": "Preferred stock, shares authorized (in shares)"
}
}
},
"localname": "PreferredStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesIssued": {
"auth_ref": [
"r11"
],
"lang": {
"en-US": {
"role": {
"documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
"label": "Preferred Stock, Shares Issued",
"terseLabel": "Preferred stock, shares issued (in shares)"
}
}
},
"localname": "PreferredStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesOutstanding": {
"auth_ref": [
"r11"
],
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
"label": "Preferred Stock, Shares Outstanding",
"terseLabel": "Preferred stock, shares outstanding (in shares)"
}
}
},
"localname": "PreferredStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockValue": {
"auth_ref": [
"r11"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 2.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Preferred Stock, Value, Issued",
"terseLabel": "Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding"
}
}
},
"localname": "PreferredStockValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PremiumsEarnedNet": {
"auth_ref": [
"r407",
"r434",
"r440",
"r456"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 1.0,
"parentTag": "us-gaap_Revenues",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
"label": "Premiums Earned, Net",
"terseLabel": "Premium revenue"
}
}
},
"localname": "PremiumsEarnedNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
"auth_ref": [
"r5",
"r21",
"r22"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 4.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
"label": "Prepaid Expense and Other Assets, Current",
"terseLabel": "Prepaid expenses and other current assets"
}
}
},
"localname": "PrepaidExpenseAndOtherAssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromConvertibleDebt": {
"auth_ref": [
"r76"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
"label": "Proceeds from Convertible Debt",
"terseLabel": "Cash received for partial settlement of call option",
"verboseLabel": "Cash received for settlement of call option"
}
}
},
"localname": "ProceedsFromConvertibleDebt",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
"auth_ref": [
"r76"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
"label": "Proceeds from Issuance of Senior Long-term Debt",
"terseLabel": "Proceeds from senior notes offering, net of issuance costs"
}
}
},
"localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromLinesOfCredit": {
"auth_ref": [
"r76",
"r100"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
"label": "Proceeds from Lines of Credit",
"terseLabel": "Proceeds from borrowings under term loan facility"
}
}
},
"localname": "ProceedsFromLinesOfCredit",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
"auth_ref": [
"r77",
"r80",
"r102"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 6.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
"label": "Proceeds from (Payments for) Other Financing Activities",
"terseLabel": "Other, net"
}
}
},
"localname": "ProceedsFromPaymentsForOtherFinancingActivities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
"label": "Proceeds from Sale and Maturity of Marketable Securities",
"terseLabel": "Proceeds from sales and maturities of investments"
}
}
},
"localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
"auth_ref": [
"r39",
"r227",
"r365"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 2.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
"label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
"terseLabel": "Property, equipment, and capitalized software, net"
}
}
},
"localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ReceivableTypeDomain": {
"auth_ref": [
"r36"
],
"lang": {
"en-US": {
"role": {
"documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
"label": "Receivable [Domain]",
"terseLabel": "Receivable [Domain]"
}
}
},
"localname": "ReceivableTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ReceivablesNetCurrent": {
"auth_ref": [
"r13",
"r20",
"r433",
"r460"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 3.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
"label": "Receivables, Net, Current",
"terseLabel": "Receivables"
}
}
},
"localname": "ReceivablesNetCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS",
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ReceivablesPolicyTextBlock": {
"auth_ref": [
"r93",
"r184",
"r186",
"r187",
"r188"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
"label": "Receivable [Policy Text Block]",
"terseLabel": "Receivables"
}
}
},
"localname": "ReceivablesPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ReinsuranceAccountingPolicy": {
"auth_ref": [
"r93",
"r425",
"r426",
"r457",
"r458"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.",
"label": "Reinsurance Accounting Policy [Policy Text Block]",
"terseLabel": "Reinsurance"
}
}
},
"localname": "ReinsuranceAccountingPolicy",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_RepaymentsOfConvertibleDebt": {
"auth_ref": [
"r79"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
"label": "Repayments of Convertible Debt",
"negatedTerseLabel": "Repayment of principal amount of convertible senior notes"
}
}
},
"localname": "RepaymentsOfConvertibleDebt",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RepaymentsOfDebt": {
"auth_ref": [
"r79"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
"label": "Repayments of Debt",
"terseLabel": "Repayments of debt"
}
}
},
"localname": "RepaymentsOfDebt",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RepaymentsOfLinesOfCredit": {
"auth_ref": [
"r79",
"r100"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 9.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
"label": "Repayments of Lines of Credit",
"negatedTerseLabel": "Repayment of term loan facility",
"terseLabel": "Repayment of principal amount outstanding"
}
}
},
"localname": "RepaymentsOfLinesOfCredit",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/DebtNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ReservesReportedToOtherAgenciesTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of reserves reported to other federal agencies or authorities.",
"label": "Reserves Reported to Other Agencies [Table Text Block]",
"terseLabel": "Amounts Due to Government Agencies"
}
}
},
"localname": "ReservesReportedToOtherAgenciesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_RestrictedCashAndCashEquivalents": {
"auth_ref": [
"r7",
"r87",
"r92",
"r401",
"r429"
],
"calculation": {
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashandCashEquivalentsDetails": {
"order": 2.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Restricted Cash and Cash Equivalents",
"verboseLabel": "Restricted cash and cash equivalents"
}
}
},
"localname": "RestrictedCashAndCashEquivalents",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashandCashEquivalentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RestrictedInvestmentsNoncurrent": {
"auth_ref": [
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 4.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "This element represents the noncurrent portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions.",
"label": "Restricted Investments, Noncurrent",
"terseLabel": "Restricted investments"
}
}
},
"localname": "RestrictedInvestmentsNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RestrictedStockMember": {
"auth_ref": [
"r130"
],
"lang": {
"en-US": {
"role": {
"documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
"label": "Restricted Stock [Member]",
"terseLabel": "RSAs"
}
}
},
"localname": "RestrictedStockMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails",
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_RestrictedStockUnitsRSUMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
"label": "Restricted Stock Units (RSUs) [Member]",
"terseLabel": "PSUs"
}
}
},
"localname": "RestrictedStockUnitsRSUMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails",
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_RetainedEarningsAccumulatedDeficit": {
"auth_ref": [
"r15",
"r253",
"r304",
"r431",
"r453",
"r455"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 5.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Retained Earnings (Accumulated Deficit)",
"terseLabel": "Retained earnings"
}
}
},
"localname": "RetainedEarningsAccumulatedDeficit",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RetainedEarningsMember": {
"auth_ref": [
"r104",
"r105",
"r106",
"r109",
"r115",
"r117",
"r212",
"r301",
"r302",
"r303",
"r314",
"r315",
"r450",
"r452"
],
"lang": {
"en-US": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Retained Earnings [Member]",
"terseLabel": "Retained Earnings"
}
}
},
"localname": "RetainedEarningsMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "domainItemType"
},
"us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
"auth_ref": [
"r94",
"r259",
"r260",
"r261",
"r262",
"r263",
"r264",
"r265",
"r266",
"r270"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for revenue from contract with customer.",
"label": "Revenue from Contract with Customer [Policy Text Block]",
"terseLabel": "Premium Revenue and Contractual Provisions That May Adjust or Limit Revenue or Profit"
}
}
},
"localname": "RevenueFromContractWithCustomerPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_Revenues": {
"auth_ref": [
"r60",
"r97",
"r151",
"r152",
"r165",
"r171",
"r172",
"r178",
"r179",
"r182",
"r211",
"r350",
"r413"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
"order": 1.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
"label": "Revenues",
"totalLabel": "Total revenue",
"verboseLabel": "Add: other operating revenues"
}
}
},
"localname": "Revenues",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RevenuesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Revenues [Abstract]",
"terseLabel": "Revenue:"
}
}
},
"localname": "RevenuesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
],
"xbrltype": "stringItemType"
},
"us-gaap_RevolvingCreditFacilityMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
"label": "Revolving Credit Facility [Member]",
"terseLabel": "Credit facility",
"verboseLabel": "Term loan facility"
}
}
},
"localname": "RevolvingCreditFacilityMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
"auth_ref": [
"r36"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
"label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
"terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
}
}
},
"localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
"auth_ref": [
"r36"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
"label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
"terseLabel": "Schedule of receivables"
}
}
},
"localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Debt Securities, Available-for-sale [Line Items]",
"terseLabel": "Debt Securities, Available-for-sale [Line Items]"
}
}
},
"localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
"label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
"terseLabel": "Available-for-Sale Investments"
}
}
},
"localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/InvestmentsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the components of cash and cash equivalents.",
"label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
"terseLabel": "Schedule of Cash and Cash Equivalents"
}
}
},
"localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
"auth_ref": [
"r32",
"r99",
"r247",
"r250",
"r251",
"r252",
"r360",
"r361",
"r363",
"r423"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
"label": "Schedule of Long-term Debt Instruments [Table Text Block]",
"terseLabel": "Schedule of Long-Term Debt"
}
}
},
"localname": "ScheduleOfDebtInstrumentsTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable": {
"auth_ref": [
"r271",
"r272",
"r288",
"r300"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule, table or text reflecting equity-based arrangements (such as stock or unit options and stock or unit awards) with individual employees, which are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability.",
"label": "Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table]",
"terseLabel": "Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table]"
}
}
},
"localname": "ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
"auth_ref": [
"r129"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
"label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
"terseLabel": "Summary of Denominators for the Computation of Basic and Diluted Net Income (Loss) Per Share"
}
}
},
"localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/NetIncomeperShareTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
"auth_ref": [
"r340",
"r341"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
"label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
"terseLabel": "Schedule of Fair Value, Asset and Liabilities Measured on Recurring Basis - Disclosure Only"
}
}
},
"localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
"auth_ref": [
"r445"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
"label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
"terseLabel": "Medical Claims and Benefits Payable"
}
}
},
"localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
"auth_ref": [
"r291"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
"label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
"terseLabel": "Restricted Share Activity"
}
}
},
"localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
"auth_ref": [
"r7",
"r92",
"r401",
"r429"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
"label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
"terseLabel": "Restricted Cash and Cash Equivalents"
}
}
},
"localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
"auth_ref": [
"r160",
"r163",
"r169",
"r225"
],
"lang": {
"en-US": {
"role": {
"documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
"label": "Schedule of Segment Reporting Information, by Segment [Table]",
"terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
}
}
},
"localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
"auth_ref": [
"r160",
"r163",
"r169",
"r225"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
"label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
"terseLabel": "Operating Segment Information"
}
}
},
"localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SegmentsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
"auth_ref": [
"r288",
"r300"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about share-based payment arrangement.",
"label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
"terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
}
}
},
"localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfStockByClassTable": {
"auth_ref": [
"r34",
"r95",
"r137",
"r138",
"r243",
"r244",
"r245",
"r247",
"r248",
"r249",
"r250",
"r251",
"r252",
"r253"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
"label": "Schedule of Stock by Class [Table]",
"terseLabel": "Schedule of Stock by Class [Table]"
}
}
},
"localname": "ScheduleOfStockByClassTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_SegmentDomain": {
"auth_ref": [
"r147",
"r151",
"r152",
"r153",
"r154",
"r155",
"r156",
"r157",
"r158",
"r159",
"r160",
"r161",
"r162",
"r165",
"r166",
"r167",
"r168",
"r170",
"r171",
"r172",
"r173",
"r174",
"r176",
"r182",
"r446"
],
"lang": {
"en-US": {
"role": {
"documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
"label": "Segments [Domain]",
"terseLabel": "Segments [Domain]"
}
}
},
"localname": "SegmentDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_SegmentReportingAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Segment Reporting [Abstract]",
"terseLabel": "Segment Reporting [Abstract]"
}
}
},
"localname": "SegmentReportingAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_SegmentReportingDisclosureTextBlock": {
"auth_ref": [
"r147",
"r149",
"r150",
"r160",
"r164",
"r170",
"r174",
"r175",
"r176",
"r177",
"r178",
"r181",
"r182",
"r183"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
"label": "Segment Reporting Disclosure [Text Block]",
"terseLabel": "Segments"
}
}
},
"localname": "SegmentReportingDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/Segments"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SegmentReportingInformationLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Segment Reporting Information [Line Items]",
"terseLabel": "Segment Reporting Information [Line Items]"
}
}
},
"localname": "SegmentReportingInformationLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_SeniorNotesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
"label": "Senior Notes [Member]",
"terseLabel": "Senior notes"
}
}
},
"localname": "SeniorNotesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/DebtNarrativeDetails",
"http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
"http://www.molinahealthcare.com/role/FairValueMeasurementsDetailsofLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ShareBasedCompensation": {
"auth_ref": [
"r84"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of noncash expense for share-based payment arrangement.",
"label": "Share-based Payment Arrangement, Noncash Expense",
"terseLabel": "Share-based compensation"
}
}
},
"localname": "ShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
"auth_ref": [
"r290"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
"negatedLabel": "Forfeited (in shares)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r295"
],
"lang": {
"en-US": {
"role": {
"documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
"terseLabel": "Forfeited (in dollars per share)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
"auth_ref": [
"r293"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
"terseLabel": "Granted (in shares)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r293"
],
"lang": {
"en-US": {
"role": {
"documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
"terseLabel": "Granted (in dollars per share)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
"auth_ref": [
"r292"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
"periodEndLabel": "Ending Balance (in shares)",
"periodStartLabel": "Beginning Balance (in shares)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
"terseLabel": "Number of Shares"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r292"
],
"lang": {
"en-US": {
"role": {
"documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
"periodEndLabel": "Ending Balance (in dollars per share)",
"periodStartLabel": "Begining Balance (in dollars per share)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
"terseLabel": "Weighted Average Grant\u00a0Date Fair Value"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
"auth_ref": [
"r294"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
"negatedLabel": "Vested (in shares)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
"auth_ref": [
"r297"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
"terseLabel": "Total vested"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r294"
],
"lang": {
"en-US": {
"role": {
"documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
"terseLabel": "Vested (in dollars per share)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
"terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Gross number of share options (or share units) granted during the period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
"terseLabel": "Stock options granted (in shares)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
"auth_ref": [
"r286",
"r289"
],
"lang": {
"en-US": {
"role": {
"documentation": "Award under share-based payment arrangement.",
"label": "Award Type [Domain]",
"terseLabel": "Award Type [Domain]"
}
}
},
"localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails",
"http://www.molinahealthcare.com/role/StockholdersEquityShareActivityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_SharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
"label": "Shares, Outstanding",
"periodEndLabel": "Ending Balance (in shares)",
"periodStartLabel": "Beginning Balance (in shares)",
"terseLabel": "Shares outstanding at the beginning of the period (in shares)"
}
}
},
"localname": "SharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_SignificantAccountingPoliciesTextBlock": {
"auth_ref": [
"r103"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
"label": "Significant Accounting Policies [Text Block]",
"terseLabel": "Significant Accounting Policies"
}
}
},
"localname": "SignificantAccountingPoliciesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_StatementBusinessSegmentsAxis": {
"auth_ref": [
"r0",
"r147",
"r151",
"r152",
"r153",
"r154",
"r155",
"r156",
"r157",
"r158",
"r159",
"r160",
"r161",
"r162",
"r165",
"r166",
"r167",
"r168",
"r170",
"r171",
"r172",
"r173",
"r174",
"r176",
"r182",
"r225",
"r228",
"r229",
"r230",
"r446"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by business segments.",
"label": "Segments [Axis]",
"terseLabel": "Segments [Axis]"
}
}
},
"localname": "StatementBusinessSegmentsAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
"http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementEquityComponentsAxis": {
"auth_ref": [
"r35",
"r104",
"r105",
"r106",
"r109",
"r115",
"r117",
"r136",
"r212",
"r246",
"r253",
"r301",
"r302",
"r303",
"r314",
"r315",
"r352",
"r353",
"r354",
"r355",
"r356",
"r357",
"r450",
"r451",
"r452"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by component of equity.",
"label": "Equity Components [Axis]",
"terseLabel": "Equity Components [Axis]"
}
}
},
"localname": "StatementEquityComponentsAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Statement [Line Items]",
"terseLabel": "Statement [Line Items]"
}
}
},
"localname": "StatementLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfCashFlowsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statement of Cash Flows [Abstract]",
"terseLabel": "Statement of Cash Flows [Abstract]"
}
}
},
"localname": "StatementOfCashFlowsAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfFinancialPositionAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statement of Financial Position [Abstract]",
"terseLabel": "Statement of Financial Position [Abstract]"
}
}
},
"localname": "StatementOfFinancialPositionAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statement of Comprehensive Income [Abstract]",
"terseLabel": "Statement of Comprehensive Income [Abstract]"
}
}
},
"localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfStockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statement of Stockholders' Equity [Abstract]",
"terseLabel": "Statement of Stockholders' Equity [Abstract]"
}
}
},
"localname": "StatementOfStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementTable": {
"auth_ref": [
"r104",
"r105",
"r106",
"r136",
"r399"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
"label": "Statement [Table]",
"terseLabel": "Statement [Table]"
}
}
},
"localname": "StatementTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockIssued1": {
"auth_ref": [
"r89",
"r90",
"r91"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The fair value of stock issued in noncash financing activities.",
"label": "Stock Issued",
"negatedTerseLabel": "Common stock used for share-based compensation"
}
}
},
"localname": "StockIssued1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
"auth_ref": [
"r11",
"r12",
"r246",
"r253"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
"label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
"terseLabel": "Number of common stock issued (in shares)",
"verboseLabel": "Share-based compensation (in shares)"
}
}
},
"localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
"auth_ref": [
"r11",
"r12",
"r253",
"r287",
"r296"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
"label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
"terseLabel": "Share-based compensation"
}
}
},
"localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of stock repurchase plan authorized.",
"label": "Stock Repurchase Program, Authorized Amount",
"terseLabel": "Authorized amount"
}
}
},
"localname": "StockRepurchaseProgramAuthorizedAmount1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockRepurchasedDuringPeriodShares": {
"auth_ref": [
"r11",
"r12",
"r246",
"r253"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
"label": "Stock Repurchased During Period, Shares",
"negatedLabel": "Common stock purchases (in shares)",
"terseLabel": "Shares repurchased (in shares)"
}
}
},
"localname": "StockRepurchasedDuringPeriodShares",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockRepurchasedDuringPeriodValue": {
"auth_ref": [
"r11",
"r12",
"r246",
"r253"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
"label": "Stock Repurchased During Period, Value",
"negatedTerseLabel": "Common stock purchases",
"terseLabel": "Shares repurchased, value"
}
}
},
"localname": "StockRepurchasedDuringPeriodValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquity": {
"auth_ref": [
"r12",
"r17",
"r18",
"r97",
"r185",
"r211",
"r350"
],
"calculation": {
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
"label": "Stockholders' Equity Attributable to Parent",
"totalLabel": "Total stockholders\u2019 equity"
}
}
},
"localname": "StockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Stockholders' Equity Attributable to Parent [Abstract]",
"terseLabel": "Stockholders\u2019 equity:"
}
}
},
"localname": "StockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDBALANCESHEETS"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
"auth_ref": [
"r97",
"r104",
"r105",
"r106",
"r109",
"r115",
"r211",
"r212",
"r253",
"r301",
"r302",
"r303",
"r314",
"r315",
"r320",
"r321",
"r330",
"r350",
"r352",
"r353",
"r357",
"r451",
"r452"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
"label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
"periodEndLabel": "Ending Balance",
"periodStartLabel": "Beginning Balance"
}
}
},
"localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
"auth_ref": [
"r96",
"r253",
"r256"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
"label": "Stockholders' Equity Note Disclosure [Text Block]",
"terseLabel": "Stockholders' Equity"
}
}
},
"localname": "StockholdersEquityNoteDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquity"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SubsequentEventMember": {
"auth_ref": [
"r358",
"r366"
],
"lang": {
"en-US": {
"role": {
"documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
"label": "Subsequent Event [Member]",
"terseLabel": "Subsequent event"
}
}
},
"localname": "SubsequentEventMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_SubsequentEventTypeAxis": {
"auth_ref": [
"r358",
"r366"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
"label": "Subsequent Event Type [Axis]",
"terseLabel": "Subsequent Event Type [Axis]"
}
}
},
"localname": "SubsequentEventTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventTypeDomain": {
"auth_ref": [
"r358",
"r366"
],
"lang": {
"en-US": {
"role": {
"documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
"label": "Subsequent Event Type [Domain]",
"terseLabel": "Subsequent Event Type [Domain]"
}
}
},
"localname": "SubsequentEventTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_SupplementalCashFlowInformationAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Supplemental Cash Flow Information [Abstract]",
"terseLabel": "Supplemental cash flow information:"
}
}
},
"localname": "SupplementalCashFlowInformationAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
],
"xbrltype": "stringItemType"
},
"us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
"auth_ref": [
"r442"
],
"calculation": {
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails": {
"order": 1.0,
"parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
"label": "Current Year Claims and Claims Adjustment Expense",
"terseLabel": "Current year"
}
}
},
"localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
"auth_ref": [
"r442"
],
"calculation": {
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails": {
"order": 2.0,
"parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
"label": "Prior Year Claims and Claims Adjustment Expense",
"negatedLabel": "Prior period claims, favorable development",
"terseLabel": "Prior periods"
}
}
},
"localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsofChangeinMedicalClaimsandBenefitsPayableDetails",
"http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableNarrativeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
"auth_ref": [
"r204",
"r205",
"r367",
"r368",
"r369",
"r370",
"r371",
"r372",
"r373",
"r374",
"r375",
"r376",
"r377",
"r378",
"r379",
"r381",
"r382",
"r383",
"r384",
"r385",
"r386",
"r387",
"r388",
"r389",
"r390",
"r391",
"r392",
"r393",
"r394",
"r395",
"r396",
"r397"
],
"lang": {
"en-US": {
"role": {
"documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
"label": "Financial Instruments [Domain]",
"terseLabel": "Financial Instruments [Domain]"
}
}
},
"localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails",
"http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleInvestmentsDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
"auth_ref": [
"r254"
],
"lang": {
"en-US": {
"role": {
"documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
"label": "Treasury Stock Acquired, Average Cost Per Share",
"terseLabel": "Shares repurchased (in dollars per share)"
}
}
},
"localname": "TreasuryStockAcquiredAverageCostPerShare",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/StockholdersEquityNarrativeDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember": {
"auth_ref": [
"r274",
"r414"
],
"lang": {
"en-US": {
"role": {
"documentation": "Debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae).",
"label": "US Government-sponsored Enterprises Debt Securities [Member]",
"verboseLabel": "GSEs"
}
}
},
"localname": "USGovernmentSponsoredEnterprisesDebtSecuritiesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_USTreasuryNotesSecuritiesMember": {
"auth_ref": [
"r414"
],
"lang": {
"en-US": {
"role": {
"documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one to ten years, are interest bearing, and are backed by the full faith and credit of the United States government.",
"label": "US Treasury Notes Securities [Member]",
"terseLabel": "U.S. Treasury notes"
}
}
},
"localname": "USTreasuryNotesSecuritiesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsonRecurringBasisDetails",
"http://www.molinahealthcare.com/role/InvestmentsSummaryofInvestmentsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_UnusualOrInfrequentItemAxis": {
"auth_ref": [
"r71"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
"label": "Unusual or Infrequent Item, or Both [Axis]",
"terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
}
}
},
"localname": "UnusualOrInfrequentItemAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_UnusualOrInfrequentItemDomain": {
"auth_ref": [
"r71"
],
"lang": {
"en-US": {
"role": {
"documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
"label": "Unusual or Infrequent Item, or Both [Domain]",
"terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
}
}
},
"localname": "UnusualOrInfrequentItemDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesNarrativeDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_UseOfEstimates": {
"auth_ref": [
"r139",
"r140",
"r142",
"r143",
"r144",
"r145",
"r146"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
"label": "Use of Estimates, Policy [Policy Text Block]",
"terseLabel": "Use of Estimates"
}
}
},
"localname": "UseOfEstimates",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
"auth_ref": [
"r120",
"r129"
],
"calculation": {
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"lang": {
"en-US": {
"role": {
"documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
"label": "Weighted Average Number of Shares Outstanding, Diluted",
"totalLabel": "Denominator for net income per share, diluted (in shares)"
}
}
},
"localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation": {
"auth_ref": [
"r119"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).",
"label": "Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation",
"negatedTerseLabel": "Stock purchases (in shares)"
}
}
},
"localname": "WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
"auth_ref": [
"r118",
"r129"
],
"calculation": {
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails": {
"order": 1.0,
"parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
"label": "Weighted Average Number of Shares Outstanding, Basic",
"terseLabel": "Denominator for net income per share, basic (in shares)"
}
}
},
"localname": "WeightedAverageNumberOfSharesOutstandingBasic",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
"terseLabel": "Weighted-average number of shares issued:"
}
}
},
"localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
"terseLabel": "Denominator:"
}
}
},
"localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.molinahealthcare.com/role/NetIncomeperShareDetails"
],
"xbrltype": "stringItemType"
}
},
"unitCount": 9
}
},
"std_ref": {
"r0": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
},
"r1": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
},
"r10": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(22))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r100": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(f))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r101": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(h)(1)(i))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r102": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.12-04(a))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
},
"r103": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "235",
"URI": "http://asc.fasb.org/topic&trid=2122369"
},
"r104": {
"Name": "Accounting Standards Codification",
"Paragraph": "23",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
},
"r105": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
},
"r106": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
},
"r107": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
},
"r108": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(2)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
},
"r109": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(3)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
},
"r11": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(28))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r110": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
},
"r111": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
},
"r112": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
},
"r113": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
},
"r114": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
},
"r115": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
},
"r116": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
},
"r117": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
},
"r118": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
},
"r119": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2646-109256"
},
"r12": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(29))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r120": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
},
"r121": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
},
"r122": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
},
"r123": {
"Name": "Accounting Standards Codification",
"Paragraph": "23",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
},
"r124": {
"Name": "Accounting Standards Codification",
"Paragraph": "26",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1828-109256"
},
"r125": {
"Name": "Accounting Standards Codification",
"Paragraph": "28A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
},
"r126": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
},
"r127": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
},
"r128": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
},
"r129": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r13": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r130": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r131": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
},
"r132": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
},
"r133": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
},
"r134": {
"Name": "Accounting Standards Codification",
"Paragraph": "52",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
},
"r135": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "260",
"URI": "http://asc.fasb.org/topic&trid=2144383"
},
"r136": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
},
"r137": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
},
"r138": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
},
"r139": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r14": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r140": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r141": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r142": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
},
"r143": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
},
"r144": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
},
"r145": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
},
"r146": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
},
"r147": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
},
"r148": {
"Name": "Accounting Standards Codification",
"Paragraph": "18",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
},
"r149": {
"Name": "Accounting Standards Codification",
"Paragraph": "21",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
},
"r15": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r150": {
"Name": "Accounting Standards Codification",
"Paragraph": "21",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
},
"r151": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r152": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r153": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r154": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r155": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r156": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r157": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(g)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r158": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r159": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(j)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r16": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(4))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r160": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r161": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
},
"r162": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
},
"r163": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
},
"r164": {
"Name": "Accounting Standards Codification",
"Paragraph": "26",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
},
"r165": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
},
"r166": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
},
"r167": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
},
"r168": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
},
"r169": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
},
"r17": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r170": {
"Name": "Accounting Standards Codification",
"Paragraph": "31",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
},
"r171": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
},
"r172": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
},
"r173": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
},
"r174": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
},
"r175": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
},
"r176": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
},
"r177": {
"Name": "Accounting Standards Codification",
"Paragraph": "34",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
},
"r178": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
},
"r179": {
"Name": "Accounting Standards Codification",
"Paragraph": "41",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
},
"r18": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(31))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r180": {
"Name": "Accounting Standards Codification",
"Paragraph": "41",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
},
"r181": {
"Name": "Accounting Standards Codification",
"Paragraph": "41",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
},
"r182": {
"Name": "Accounting Standards Codification",
"Paragraph": "42",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
},
"r183": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "280",
"URI": "http://asc.fasb.org/topic&trid=2134510"
},
"r184": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
},
"r185": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 4.E)",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
},
"r186": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
},
"r187": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
},
"r188": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
},
"r189": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
},
"r19": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(32))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r190": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
},
"r191": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
},
"r192": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(aa)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
},
"r193": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
},
"r194": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
},
"r195": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
},
"r196": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
},
"r197": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
},
"r198": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
},
"r199": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
},
"r2": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "205",
"URI": "http://asc.fasb.org/topic&trid=2122149"
},
"r20": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(4))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r200": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
},
"r201": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
},
"r202": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(1)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
},
"r203": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
},
"r204": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
},
"r205": {
"Name": "Accounting Standards Codification",
"Paragraph": "5A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
},
"r206": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563"
},
"r207": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
},
"r208": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
},
"r209": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "320",
"URI": "http://asc.fasb.org/topic&trid=2196928"
},
"r21": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(7))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r210": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(2)",
"Topic": "323",
"URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
},
"r211": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "323",
"URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
},
"r212": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
},
"r213": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
},
"r214": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
},
"r215": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
},
"r216": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
},
"r217": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
},
"r218": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
},
"r219": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)(3)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
},
"r22": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(8))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r220": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
},
"r221": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922890-210455"
},
"r222": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
},
"r223": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
},
"r224": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "30",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
},
"r225": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
},
"r226": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r227": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r228": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
},
"r229": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
},
"r23": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.1)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r230": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 5.P.4(d))",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
},
"r231": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "440",
"URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
},
"r232": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "440",
"URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
},
"r233": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "440",
"URI": "http://asc.fasb.org/topic&trid=2144648"
},
"r234": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
},
"r235": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
},
"r236": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
},
"r237": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "450",
"URI": "http://asc.fasb.org/topic&trid=2127136"
},
"r238": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
},
"r239": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "20",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606"
},
"r24": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.17)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r240": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "40",
"SubTopic": "50",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
},
"r241": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "40",
"SubTopic": "50",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
},
"r242": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "470",
"URI": "http://asc.fasb.org/topic&trid=2208564"
},
"r243": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(CFRR 211.02)",
"Topic": "480",
"URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
},
"r244": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
},
"r245": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
},
"r246": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
},
"r247": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
},
"r248": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
},
"r249": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
},
"r25": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19(b),22(b))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r250": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
},
"r251": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
},
"r252": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
},
"r253": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.3-04)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
},
"r254": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
},
"r255": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "50",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
},
"r256": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "505",
"URI": "http://asc.fasb.org/topic&trid=2208762"
},
"r257": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
},
"r258": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
},
"r259": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
},
"r26": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19,20)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r260": {
"Name": "Accounting Standards Codification",
"Paragraph": "18",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
},
"r261": {
"Name": "Accounting Standards Codification",
"Paragraph": "18",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
},
"r262": {
"Name": "Accounting Standards Codification",
"Paragraph": "19",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
},
"r263": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
},
"r264": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
},
"r265": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
},
"r266": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
},
"r267": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
},
"r268": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
},
"r269": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
},
"r27": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19-26)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r270": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "606",
"URI": "http://asc.fasb.org/topic&trid=49130388"
},
"r271": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "30",
"SubTopic": "10",
"Topic": "710",
"URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
},
"r272": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "710",
"URI": "http://asc.fasb.org/extlink&oid=6409961&loc=d3e20517-108367"
},
"r273": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(i)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r274": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(ii)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r275": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(01)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r276": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(02)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r277": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(02)(A)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r278": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(02)(B)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r279": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(02)(C)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r28": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.2)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r280": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(03)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r281": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
},
"r282": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "80",
"Subparagraph": "(a)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
},
"r283": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "80",
"Subparagraph": "(d)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
},
"r284": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "80",
"Subparagraph": "(a)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
},
"r285": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "80",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
},
"r286": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
},
"r287": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
},
"r288": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
},
"r289": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a),(g)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r29": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.20)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r290": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)(iv)(3)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r291": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r292": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)(i)-(ii)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r293": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)(iii)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r294": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)(iii)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r295": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)(iii)(3)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r296": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r297": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r298": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(g)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r299": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(i)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r3": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
},
"r30": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.21)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r300": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r301": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r302": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(f)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r303": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(f)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r304": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(g)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r305": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
},
"r306": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
},
"r307": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
},
"r308": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
},
"r309": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
},
"r31": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.22(a)(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r310": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
},
"r311": {
"Name": "Accounting Standards Codification",
"Paragraph": "19",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
},
"r312": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
},
"r313": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
},
"r314": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)(2)",
"Topic": "740"
},
"r315": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)(3)",
"Topic": "740"
},
"r316": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB TOPIC 6.I.7)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
},
"r317": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
},
"r318": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r319": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
},
"r32": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.22)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r320": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
},
"r321": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
},
"r322": {
"Name": "Accounting Standards Codification",
"Paragraph": "19",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
},
"r323": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
},
"r324": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
},
"r325": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
},
"r326": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(3)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r327": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c),(3)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r328": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bb)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
},
"r329": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
},
"r33": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.24)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r330": {
"Name": "Accounting Standards Codification",
"Paragraph": "4I",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
},
"r331": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "810",
"URI": "http://asc.fasb.org/topic&trid=2197479"
},
"r332": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
},
"r333": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
},
"r334": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(1)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
},
"r335": {
"Name": "Accounting Standards Codification",
"Paragraph": "4B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a),(c)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
},
"r336": {
"Name": "Accounting Standards Codification",
"Paragraph": "4B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
},
"r337": {
"Name": "Accounting Standards Codification",
"Paragraph": "4B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
},
"r338": {
"Name": "Accounting Standards Codification",
"Paragraph": "4C",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
},
"r339": {
"Name": "Accounting Standards Codification",
"Paragraph": "4D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
},
"r34": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.28,29)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r340": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r341": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r342": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bb)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r343": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r344": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
},
"r345": {
"Name": "Accounting Standards Codification",
"Paragraph": "6A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
},
"r346": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
},
"r347": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
},
"r348": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
},
"r349": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
},
"r35": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.29-31)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r350": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
},
"r351": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "230",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
},
"r352": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
},
"r353": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r354": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r355": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(c)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r356": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(d)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r357": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
},
"r358": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
},
"r359": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
},
"r36": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.3,4)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r360": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
},
"r361": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
},
"r362": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
},
"r363": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
},
"r364": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
},
"r365": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
},
"r366": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "855",
"URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
},
"r367": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(2)(i)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r368": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(2)(ii)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r369": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(3)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r37": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.8)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r370": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)(1)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r371": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)(2)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r372": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)(3)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r373": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)(1)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r374": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)(2)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r375": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)(3)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r376": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(1)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
},
"r377": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(2)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
},
"r378": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(3)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
},
"r379": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
},
"r38": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.9)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r380": {
"Name": "Accounting Standards Codification",
"Paragraph": "4D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)(2)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
},
"r381": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
},
"r382": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
},
"r383": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(a)(1)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
},
"r384": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(a)(2)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
},
"r385": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(a)(3)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
},
"r386": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(a)(4)(i)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
},
"r387": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(a)(1)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
},
"r388": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(a)(2)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
},
"r389": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(a)(3)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
},
"r39": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX210.5-02(13))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r390": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(a)(4)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
},
"r391": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(a)(5)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
},
"r392": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(a)(6)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
},
"r393": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(a)(7)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
},
"r394": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(b)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
},
"r395": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(e)(1)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
},
"r396": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(e)(2)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
},
"r397": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "50",
"Subparagraph": "(e)(3)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
},
"r398": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "910",
"URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
},
"r399": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 11.L)",
"Topic": "924",
"URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
},
"r4": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
},
"r40": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
},
"r400": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"SubTopic": "320",
"Topic": "940",
"URI": "http://asc.fasb.org/subtopic&trid=2176304"
},
"r401": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(1)(a))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r402": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(11))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r403": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(13))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r404": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(16))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r405": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(23))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r406": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(6))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r407": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(13)(c))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r408": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(22))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r409": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(26))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r41": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
},
"r410": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(27))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r411": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04.1-5)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r412": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04.9)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r413": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "235",
"Subparagraph": "(SX 210.9-05(b)(2))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
},
"r414": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "320",
"Subparagraph": "(b)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
},
"r415": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "320",
"Subparagraph": "(a)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
},
"r416": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "320",
"Subparagraph": "(b)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
},
"r417": {
"Name": "Accounting Standards Codification",
"Paragraph": "3A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "320",
"Subparagraph": "(a)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
},
"r418": {
"Name": "Accounting Standards Codification",
"Paragraph": "3A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "320",
"Subparagraph": "(b)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
},
"r419": {
"Name": "Accounting Standards Codification",
"Paragraph": "3A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "320",
"Subparagraph": "(c)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
},
"r42": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
},
"r420": {
"Name": "Accounting Standards Codification",
"Paragraph": "3A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "320",
"Subparagraph": "(d)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
},
"r421": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"SubTopic": "320",
"Topic": "942",
"URI": "http://asc.fasb.org/subtopic&trid=2209399"
},
"r422": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "405",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
},
"r423": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "470",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
},
"r424": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "825",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
},
"r425": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387"
},
"r426": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6816-158387"
},
"r427": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(16))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r428": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(12))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r429": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(2))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r43": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
},
"r430": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r431": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r432": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(25))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r433": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(5))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r434": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(1))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r435": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(18))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r436": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(22))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r437": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(23))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r438": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(3)(b))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r439": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(9))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r44": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
},
"r440": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "235",
"Subparagraph": "(SX 210.12-17(Column E))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
},
"r441": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Subparagraph": "(a)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
},
"r442": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Subparagraph": "(b)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
},
"r443": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Subparagraph": "(c)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
},
"r444": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Subparagraph": "(cc)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
},
"r445": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
},
"r446": {
"Name": "Accounting Standards Codification",
"Paragraph": "4H",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
},
"r447": {
"Name": "Accounting Standards Codification",
"Paragraph": "7A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Subparagraph": "(d)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
},
"r448": {
"Name": "Accounting Standards Codification",
"Paragraph": "13H",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "40",
"Subparagraph": "(b)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
},
"r449": {
"Name": "Accounting Standards Codification",
"Paragraph": "29F",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "40",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
},
"r45": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
},
"r450": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(e)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
},
"r451": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)(1)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
},
"r452": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)(2)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
},
"r453": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(g)(2)(i)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
},
"r454": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(g)(2)(ii)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
},
"r455": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(h)(2)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
},
"r456": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "605",
"Subparagraph": "(c)(3)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
},
"r457": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "605",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=99379264&loc=d3e27758-158548"
},
"r458": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "605",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=99379264&loc=d3e27830-158548"
},
"r459": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "80",
"Subparagraph": "(e)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
},
"r46": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
},
"r460": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.6-06(3))",
"Topic": "946",
"URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
},
"r461": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"SubTopic": "320",
"Topic": "946",
"URI": "http://asc.fasb.org/subtopic&trid=2324412"
},
"r462": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "310",
"Subparagraph": "(SX 210.12-29(Footnote 4))",
"Topic": "948",
"URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
},
"r463": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "740",
"Topic": "954",
"URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
},
"r464": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "360",
"Subparagraph": "(SX 210.12-28(Column B))",
"Topic": "970",
"URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
},
"r465": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "360",
"Subparagraph": "(SX 210.12-28(Column C))",
"Topic": "970",
"URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
},
"r466": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "360",
"Subparagraph": "(SX 210.12-28(Column D))",
"Topic": "970",
"URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
},
"r467": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "360",
"Subparagraph": "(SX 210.12-28(Column E))",
"Topic": "970",
"URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
},
"r468": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "360",
"Subparagraph": "(SX 210.12-28(Column F))",
"Topic": "970",
"URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
},
"r469": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "360",
"Subparagraph": "(SX 210.12-28(Column G))",
"Topic": "970",
"URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
},
"r47": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
},
"r470": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "360",
"Subparagraph": "(SX 210.12-28(Column H))",
"Topic": "970",
"URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
},
"r471": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "360",
"Subparagraph": "(SX 210.12-28(Column I))",
"Topic": "970",
"URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
},
"r472": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "360",
"Subparagraph": "(SX 210.12-28(Footnote 2))",
"Topic": "970",
"URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
},
"r473": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b"
},
"r474": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "d1-1"
},
"r475": {
"Name": "Form 10-Q",
"Number": "240",
"Publisher": "SEC",
"Section": "13",
"Subsection": "a-13"
},
"r476": {
"Name": "Forms 10-K, 10-Q, 20-F",
"Number": "240",
"Publisher": "SEC",
"Section": "13",
"Subsection": "a-1-"
},
"r477": {
"Name": "Regulation 12B",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b-2"
},
"r478": {
"Name": "Regulation S-T",
"Number": "232",
"Publisher": "SEC",
"Section": "405"
},
"r48": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
},
"r49": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
},
"r5": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
},
"r50": {
"Name": "Accounting Standards Codification",
"Paragraph": "14A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
},
"r51": {
"Name": "Accounting Standards Codification",
"Paragraph": "17B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
},
"r52": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
},
"r53": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
},
"r54": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
},
"r55": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
},
"r56": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
},
"r57": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
},
"r58": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
},
"r59": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(210.5-03(11))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r6": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
},
"r60": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(1))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r61": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(20))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r62": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(24))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r63": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(25))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r64": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r65": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.1,2)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r66": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.2(a),(d))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r67": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.3)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r68": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.4)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r69": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.7)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r7": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r70": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.9)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r71": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
},
"r72": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
},
"r73": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
},
"r74": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
},
"r75": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
},
"r76": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
},
"r77": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
},
"r78": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
},
"r79": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
},
"r8": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(19))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r80": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
},
"r81": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
},
"r82": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(g)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
},
"r83": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
},
"r84": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
},
"r85": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
},
"r86": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
},
"r87": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
},
"r88": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
},
"r89": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
},
"r9": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(20))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r90": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
},
"r91": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
},
"r92": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
},
"r93": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
},
"r94": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
},
"r95": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(d))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r96": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(e)(1))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r97": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(g)(1)(ii))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r98": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(h))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r99": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(e),(f))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
}
},
"version": "2.1"
} |
